{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 10572, "items": [{"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T19:19:11Z", "timestamp": 1574104751108}, "reference-count": 21, "publisher": "Elsevier BV", "issue": "10", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1996, 2, 1]], "date-time": "1996-02-01T00:00:00Z", "timestamp": 823132800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Life Sciences"], "published-print": {"date-parts": [[1996, 2]]}, "DOI": "10.1016/0024-3205(96)00014-8", "type": "journal-article", "created": {"date-parts": [[2002, 7, 25]], "date-time": "2002-07-25T22:35:57Z", "timestamp": 1027636557000}, "page": "817-827", "source": "Crossref", "is-referenced-by-count": 35, "title": ["(\u2212)Deprenyl and (\u2212)1-phenyl-2-propylaminopentane, [(\u2212) PPAP] act primarily as potent stimulants of action potential \u2014 transmitter release coupling in the catecholaminergic neurons"], "prefix": "10.1016", "volume": "58", "author": [{"given": "Joseph", "family": "Knoll", "sequence": "first", "affiliation": []}, {"given": "Ildik\u00f3", "family": "Miklya", "sequence": "additional", "affiliation": []}, {"given": "Berta", "family": "Knoll", "sequence": "additional", "affiliation": []}, {"given": "Raissa", "family": "Mark\u00f3", "sequence": "additional", "affiliation": []}, {"given": "K\u00e1roly", "family": "Kelemen", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Life Sciences"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:0024320596000148?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:0024320596000148?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 19]], "date-time": "2019-04-19T02:26:52Z", "timestamp": 1555640812000}, "score": 112.50111, "issued": {"date-parts": [[1996, 2]]}, "references-count": 21, "journal-issue": {"published-print": {"date-parts": [[1996, 2]]}, "issue": "10"}, "alternative-id": ["0024320596000148"], "URL": "http://dx.doi.org/10.1016/0024-3205(96)00014-8", "ISSN": ["0024-3205"], "issn-type": [{"value": "0024-3205", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T18:37:28Z", "timestamp": 1575311848703}, "reference-count": 2, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1992, 5, 1]], "date-time": "1992-05-01T00:00:00Z", "timestamp": 704678400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Pharmacological Research"], "published-print": {"date-parts": [[1992, 5]]}, "DOI": "10.1016/1043-6618(92)90280-o", "type": "journal-article", "created": {"date-parts": [[2008, 10, 10]], "date-time": "2008-10-10T02:28:00Z", "timestamp": 1223605680000}, "page": "48-49", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Analysis of the mechanism of the action of the psychostimulant effect of 1-phenyl-2-propylaminopentane (PPAP). A comparison with amphetamine"], "prefix": "10.1016", "volume": "25", "author": [{"given": "B.", "family": "Knoll", "sequence": "first", "affiliation": []}, {"given": "J.", "family": "Tim\u00e1r", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Knoll", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Pharmacological Research"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:104366189290280O?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:104366189290280O?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 17]], "date-time": "2019-04-17T01:21:48Z", "timestamp": 1555464108000}, "score": 52.15302, "issued": {"date-parts": [[1992, 5]]}, "references-count": 2, "alternative-id": ["104366189290280O"], "URL": "http://dx.doi.org/10.1016/1043-6618(92)90280-o", "ISSN": ["1043-6618"], "issn-type": [{"value": "1043-6618", "type": "print"}], "subject": ["Pharmacology"]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T03:26:39Z", "timestamp": 1574133999691}, "reference-count": 12, "publisher": "Elsevier BV", "issue": "18", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2002, 9, 1]], "date-time": "2002-09-01T00:00:00Z", "timestamp": 1030838400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Life Sciences"], "published-print": {"date-parts": [[2002, 9]]}, "DOI": "10.1016/s0024-3205(02)01969-0", "type": "journal-article", "created": {"date-parts": [[2002, 10, 9]], "date-time": "2002-10-09T11:31:29Z", "timestamp": 1034163089000}, "page": "2137-2144", "source": "Crossref", "is-referenced-by-count": 11, "title": ["Stimulation of the catecholaminergic and serotoninergic neurons in the rat brain by R-(\u2212)-1-(benzofuran-2-yl)-2-propylaminopentane, (\u2212)-BPAP"], "prefix": "10.1016", "volume": "71", "author": [{"given": "Joseph", "family": "Knoll", "sequence": "first", "affiliation": []}, {"given": "Ildik\u00f3", "family": "Miklya", "sequence": "additional", "affiliation": []}, {"given": "Berta", "family": "Knoll", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Life Sciences"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0024320502019690?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0024320502019690?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 10]], "date-time": "2019-04-10T05:22:00Z", "timestamp": 1554873720000}, "score": 48.01767, "issued": {"date-parts": [[2002, 9]]}, "references-count": 12, "journal-issue": {"published-print": {"date-parts": [[2002, 9]]}, "issue": "18"}, "alternative-id": ["S0024320502019690"], "URL": "http://dx.doi.org/10.1016/s0024-3205(02)01969-0", "ISSN": ["0024-3205"], "issn-type": [{"value": "0024-3205", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T06:44:04Z", "timestamp": 1574145844854}, "reference-count": 2, "publisher": "Elsevier BV", "issue": "3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1994, 9, 1]], "date-time": "1994-09-01T00:00:00Z", "timestamp": 778377600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Neuropsychopharmacology"], "published-print": {"date-parts": [[1994, 9]]}, "DOI": "10.1016/0924-977x(94)90109-0", "type": "journal-article", "created": {"date-parts": [[2002, 12, 14]], "date-time": "2002-12-14T09:03:24Z", "timestamp": 1039856604000}, "page": "298-299", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Reversal of shuttle-box deficit by 1-phenyl-2-propylaminopentane (PPAP)"], "prefix": "10.1016", "volume": "4", "author": [{"given": "S.", "family": "Gyarmati", "sequence": "first", "affiliation": []}, {"given": "J.", "family": "Tim\u00e1r", "sequence": "additional", "affiliation": []}, {"given": "L.", "family": "Barna", "sequence": "additional", "affiliation": []}, {"given": "B.", "family": "Knoll", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Knoll", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Neuropsychopharmacology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:0924977X94901090?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:0924977X94901090?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 1]], "date-time": "2019-04-01T14:21:00Z", "timestamp": 1554128460000}, "score": 45.523277, "issued": {"date-parts": [[1994, 9]]}, "references-count": 2, "journal-issue": {"published-print": {"date-parts": [[1994, 9]]}, "issue": "3"}, "alternative-id": ["0924977X94901090"], "URL": "http://dx.doi.org/10.1016/0924-977x(94)90109-0", "ISSN": ["0924-977X"], "issn-type": [{"value": "0924-977X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T20:51:55Z", "timestamp": 1574455915788}, "reference-count": 86, "publisher": "Wiley", "issue": "3", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 3373, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1111/j.1527-3458.2001.tb00202.x", "type": "journal-article", "created": {"date-parts": [[2010, 8, 13]], "date-time": "2010-08-13T20:50:31Z", "timestamp": 1281732631000}, "page": "317-345", "source": "Crossref", "is-referenced-by-count": 24, "title": ["Antiaging Compounds: (-)Deprenyl (Selegiline) and (-)1-(Benzofuran-2-yl)-2-propylaminopentane, [(-)BPAP], a Selective Highly Potent Enhancer of the Impulse Propagation Mediated Release of Catecholamines and Serotonin in the Brain"], "prefix": "10.1111", "volume": "7", "author": [{"given": "J.", "family": "Knoll", "sequence": "first", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2006, 6, 7]]}, "reference": [{"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "31", "DOI": "10.1016/0924-977X(92)90033-5", "article-title": "CBF and cognitive evaluation of Alzheimer-type patients before and after MAO-B treatment: A pilot study", "volume": "2", "author": "Agnoli", "year": "1992", "journal-title": "Eur Neuropsychopharmacol"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB2|cit2", "doi-asserted-by": "crossref", "first-page": "73", "DOI": "10.1111/j.1600-0404.1991.tb05024.x", "article-title": "Selegiline in de novo parkinsonian patients: The French selegiline multicenter trial (FSMP)", "volume": "136", "author": "Allain", "year": "1991", "journal-title": "Acta Neurol Scand"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB3|cit3", "doi-asserted-by": "crossref", "first-page": "B448", "DOI": "10.1093/gerona/51A.6.B448", "article-title": "L-Deprenyl treatment in aged mice slightly increases lifespans and greatly reduces fecundity by aged males", "volume": "13A", "author": "Archer", "year": "1996", "journal-title": "J Gerontol Sci"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB4|cit4", "doi-asserted-by": "crossref", "first-page": "560", "DOI": "10.1007/BF00343235", "article-title": "Der L-Dioxyphenyl-alanin-Effekt beim Parkinson Syndrom des Menschen", "volume": "203", "author": "Birkmayer", "year": "1962", "journal-title": "Arch Psychiat Nervenkrh"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB5|cit5", "author": "Birkmayer", "first-page": "1", "year": "1983", "volume-title": "Parkinson's Disease. Biochemistry, Clinical Pathology and Treatment"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB6|cit6", "doi-asserted-by": "crossref", "first-page": "439", "DOI": "10.1016/S0140-6736(77)91940-7", "article-title": "Implications of combined treatment with \u201cMadopar\u201d and L-Deprenil in Parkinson's disease", "volume": "1", "author": "Birkmayer", "year": "1977", "journal-title": "Lancet"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB7|cit7", "doi-asserted-by": "crossref", "first-page": "81", "DOI": "10.1007/BF01249880", "article-title": "L-Deprenyl plus L-phenylalanine in the treatment of depression", "volume": "59", "author": "Birkmayer", "year": "1984", "journal-title": "J Neural Transm"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB8|cit8", "doi-asserted-by": "crossref", "first-page": "113", "DOI": "10.1007/BF01245973", "article-title": "Increased life expectancy resulting from addition of L-deprenyl to Madopar treatment in Parkinson's disease: A long-term study", "volume": "64", "author": "Birkmayer", "year": "1985", "journal-title": "J Neural Transm"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB9|cit9", "doi-asserted-by": "crossref", "first-page": "1219", "DOI": "10.1111/j.1532-5415.1993.tb07306.x", "article-title": "L-Deprenyl in the treatment of mild dementia of the Alzheimer type: Results of a 15-month trial", "volume": "41", "author": "Burke", "year": "1993", "journal-title": "J Am Geriatr Soc"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB10|cit10", "first-page": "306", "article-title": "Selegiline versus L-acetylcarnitine in the treatment of Alzheimer-type dementia", "volume": "12", "author": "Campi", "year": "1990", "journal-title": "Clin Ther"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB11|cit11", "doi-asserted-by": "crossref", "first-page": "517", "DOI": "10.1016/0024-3205(91)90466-O", "article-title": "(-)Deprenyl induces activities of both superoxide dismutase and catalase but not of glutathion peroxidase in the striatum of young male rats", "volume": "48", "author": "Carrillo", "year": "1991", "journal-title": "Life Sci"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB12|cit12", "doi-asserted-by": "crossref", "first-page": "286", "DOI": "10.1016/0014-4886(92)90008-E", "article-title": "(-)Deprenyl increases activities of superoxide dismutase and catalase in striatum but not in hippocampus: The sex- and age-related differences in the optimal dose in the rat", "volume": "116", "author": "Carrillo", "year": "1992", "journal-title": "Exp Neurol"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB13|cit13", "doi-asserted-by": "crossref", "first-page": "209", "DOI": "10.1016/0014-2999(84)90700-3", "article-title": "Pargyline and (-)deprenyl prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetra-hydropyridine (MPTP) in monkeys", "volume": "106", "author": "Cohen", "year": "1984", "journal-title": "Eur J Pharmacol"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB14|cit14", "doi-asserted-by": "crossref", "first-page": "33", "DOI": "10.1007/BF00426954", "article-title": "Deprenyl administration in man: A selective monoamine oxidase B inhibitor without the \u201ccheese effect", "volume": "57", "author": "Elsworth", "year": "1978", "journal-title": "Psychopharmacology"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB15|cit15", "first-page": "376", "article-title": "Selegiline versus oxiracetam in patients with Alzheimer-type dementia", "volume": "12", "author": "Falsaperle", "year": "1990", "journal-title": "Clin Ther"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB16|cit16", "doi-asserted-by": "crossref", "first-page": "141", "DOI": "10.1007/BF02226963", "article-title": "Alzheimer-type dementia and verbal memory performances: Influence of selegiline therapy", "volume": "13", "author": "Finali", "year": "1992", "journal-title": "Ital J Neurol Sci"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB17|cit17", "doi-asserted-by": "crossref", "first-page": "523", "DOI": "10.1097/00002826-199112000-00005", "article-title": "L-deprenyl therapy improves verbal memory in amnesic Alzheimer patients", "volume": "14", "author": "Finali", "year": "1991", "journal-title": "Clin Neuropharmacol"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB18|cit18", "doi-asserted-by": "crossref", "first-page": "119", "DOI": "10.1016/0014-2999(90)90672-S", "article-title": "Protection against DSP-4 induced neurotoxicity by deprenyl is not related to its inhibition of MAO-B", "volume": "184", "author": "Finnegan", "year": "1990", "journal-title": "Eur J Pharmacol"}, {"issue": "Suppl", "key": "10.1111/j.1527-3458.2001.tb00202.x-BIB19|cit19", "doi-asserted-by": "crossref", "first-page": "315", "DOI": "10.1007/978-3-7091-6499-0_32", "article-title": "Long term administration of (-)deprenyl increases mortality in male Wistar rats", "volume": "52", "author": "Gallagher", "year": "1998", "journal-title": "J Neural Transm"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB20|cit20", "first-page": "342", "article-title": "The use of selegiline in Alzheimer's patients with behavior problems", "volume": "52", "author": "Goad", "year": "1991", "journal-title": "J Clin Psychiatry"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB21|cit21", "doi-asserted-by": "crossref", "first-page": "95", "DOI": "10.1016/S0165-3806(99)00195-9", "article-title": "Evidence of deprenyl-insensitive apoptosis of nigral dopamine neurons during development", "volume": "120", "author": "Groc", "year": "2000", "journal-title": "Brain Res Dev Brain Res"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB22|cit22", "first-page": "297", "article-title": "Inhibition by (-)-deprenyl of dopamine uptake in rat striatum: A possible correlation between dopamine uptake and acetylcholine release inhibition", "volume": "31", "author": "H\u00e1rsing", "year": "1979", "journal-title": "Pol J Pharmacol Pharm"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB23|cit23", "doi-asserted-by": "crossref", "first-page": "431", "DOI": "10.1016/0197-4580(93)90101-G", "article-title": "Chronic treatment of aged mice with L-deprenyl produced marked MAO-B inhibition but no beneficial effects on survival, motor performance, or nigral lipofuscin accumulation", "volume": "14", "author": "Ingram", "year": "1993", "journal-title": "Neurobiol Aging"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB24|cit24", "doi-asserted-by": "crossref", "first-page": "281", "DOI": "10.1016/0024-3205(93)90219-S", "article-title": "Chronic treatment of (-)deprenyl prolongs the lifespan of male Fischer 344 rats. Further evidence", "volume": "52", "author": "Kitani", "year": "1992", "journal-title": "Life Sci"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB25|cit25", "first-page": "65", "article-title": "Experimental studies on the higher nervous activity of animals. VI. Further studies on active reflexes", "volume": "12", "author": "Knoll", "year": "1957", "journal-title": "Acta Physiol Hung"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB26|cit26", "author": "Knoll", "first-page": "1", "year": "1969", "volume-title": "The Theory of Active Reflexes. An Analysis of Some Fundamental Mechanisms of Higher Nervous Activity"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB27|cit27", "author": "Knoll", "first-page": "131", "year": "1976", "volume-title": "Monoamine Oxidase and Its Inhibition"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB28|cit28", "doi-asserted-by": "crossref", "first-page": "177", "DOI": "10.1007/BF01246955", "article-title": "The possible mechanism of action of (-)deprenyl in Parkinson's disease", "volume": "43", "author": "Knoll", "year": "1978", "journal-title": "J Neural Transm"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB29|cit29", "author": "Knoll", "first-page": "107", "year": "1982", "volume-title": "Strategy in Drug Research"}, {"issue": "Suppl", "key": "10.1111/j.1527-3458.2001.tb00202.x-BIB30|cit30", "doi-asserted-by": "crossref", "first-page": "57", "DOI": "10.1111/j.1600-0404.1983.tb01517.x", "article-title": "Deprenyl (selegiline). The history of its development and pharmacological action", "volume": "59", "author": "Knoll", "year": "1983", "journal-title": "Acta Neurol Scand"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB31|cit31", "doi-asserted-by": "crossref", "first-page": "237", "DOI": "10.1016/0047-6374(88)90128-5", "article-title": "The striatal dopamine dependency of lifespan in male rats. Longevity study with (-)deprenyl", "volume": "46", "author": "Knoll", "year": "1988", "journal-title": "Mech Ageing Dev"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB32|cit32", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1002/syn.10238", "article-title": "Baclofen antagonizes nicotine-, cocaine-, and morphineinduced dopaminie release in the nucleus accumbens of rat", "volume": "50", "author": "Fadda", "year": "2003", "journal-title": "Synapse"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB33|cit33", "first-page": "425", "article-title": "Nigrostriatal dopaminergic activity, deprenyl treatment, and longevity", "volume": "53", "author": "Knoll", "year": "1990", "journal-title": "Adv Neurol"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB34|cit34", "doi-asserted-by": "crossref", "first-page": "505", "DOI": "10.1002/med.2610120504", "article-title": "Pharmacological basis of the therapeutic effect of (-)deprenyl in age-related neurological diseases", "volume": "12", "author": "Knoll", "year": "1992", "journal-title": "Med Res Rev"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB35|cit35", "doi-asserted-by": "crossref", "first-page": "65", "DOI": "10.1111/j.1600-0773.1994.tb00326.x", "article-title": "Memories of my 45 years in research", "volume": "75", "author": "Knoll", "year": "1994", "journal-title": "Pharmacol Toxicol"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB36|cit36", "doi-asserted-by": "crossref", "first-page": "187", "DOI": "10.1016/0753-3322(96)82619-9", "article-title": "Rationale for (-)deprenyl (selegiline) medication in Parkinson's disease and in prevention of age-related nigral changes", "volume": "49", "author": "Knoll", "year": "1995", "journal-title": "Biomed Pharmacother"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB37|cit37", "doi-asserted-by": "crossref", "first-page": "57", "DOI": "10.1111/j.1600-0773.1998.tb01399.x", "article-title": "(-)Deprenyl (selegiline), a catecholaminergic activity enhancer (CAE) substance acting in the brain", "volume": "82", "author": "Knoll", "year": "1998", "journal-title": "Pharmacol Toxicol"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB38|cit38", "first-page": "393", "article-title": "Some puzzling effects of monoamine oxidase inhibitors", "volume": "5", "author": "Knoll", "year": "1972", "journal-title": "Adv Bioch Psychopharmacol"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB39|cit39", "doi-asserted-by": "crossref", "first-page": "611", "DOI": "10.1016/0024-3205(94)00494-D", "article-title": "Enhanced catecholaminergic and serotoninergic activity in rat brain from weaning to sexual maturity. Rationale for prophylactic (-)deprenyl (selegiline) medication", "volume": "56", "author": "Knoll", "year": "1995", "journal-title": "Life Sci"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB40|cit40", "first-page": "154", "article-title": "Phenylisopropylmethyl- propinylamine (E-250), a new psychic energizer", "volume": "155", "author": "Knoll", "year": "1965", "journal-title": "Arch Int Pharmacodyn Ther"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB41|cit41", "first-page": "109", "article-title": "Phenylisopropylmethylpropinylamine (E-250), a monoamine oxidase inhibitor antagonizing the effects of tyramine", "volume": "18", "author": "Knoll", "year": "1968", "journal-title": "Arzneimittelforschung"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB42|cit42", "doi-asserted-by": "crossref", "first-page": "135", "DOI": "10.1159/000407510", "article-title": "Long-lasting, true aphrodisiac effect of (-)deprenyl in sexually sluggish old male rats", "volume": "19", "author": "Knoll", "year": "1983", "journal-title": "Mod Prob Pharmacopsychiatry"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB43|cit43", "doi-asserted-by": "crossref", "first-page": "525", "DOI": "10.1016/0024-3205(89)90103-3", "article-title": "Striatal dopamine, sexual activity and lifespan. Longevity of rats treated with (-)deprenyl", "volume": "45", "author": "Knoll", "year": "1989", "journal-title": "Life Sci"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB44|cit44", "first-page": "5", "article-title": "The pharmacology of 1-phenyl-2-propylaminopentane (PPAP), a deprenyl-derived new spectrum psychostimulant", "volume": "316", "author": "Knoll", "year": "1992", "journal-title": "Arch Int Pharmacodyn Ther"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB45|cit45", "doi-asserted-by": "crossref", "first-page": "157", "DOI": "10.1016/0047-6374(92)90061-H", "article-title": "(-)Deprenyl and (-)parafluorodeprenyl- treatment prevents age-related pigment changes in the substantia nigra. A TV-image analysis of neuromelanin", "volume": "63", "author": "Knoll", "year": "1992", "journal-title": "Mech Ageing Dev"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB46|cit46", "doi-asserted-by": "crossref", "first-page": "1047", "DOI": "10.1016/0024-3205(94)00415-3", "article-title": "Sexually low performing male rats die earlier than their high performing peers and (-)deprenyl treatment eliminates this difference", "volume": "54", "author": "Knoll", "year": "1994", "journal-title": "Life Sci"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB47|cit47", "doi-asserted-by": "crossref", "first-page": "817", "DOI": "10.1016/0024-3205(96)00014-8", "article-title": "(-)Deprenyl and (-)1-phenyl-2-propylaminopentane, [(-)PPAP], act primarily as potent stimulants of action potential-transmitter release coupling in the catecholaminergic neurons", "volume": "58", "author": "Knoll", "year": "1996", "journal-title": "Life Sci"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB48|cit48", "doi-asserted-by": "crossref", "first-page": "2101", "DOI": "10.1016/0024-3205(96)00204-4", "article-title": "Phenylethylamine and tyramine are mixed-acting sympathomimetic amines in the brain", "volume": "58", "author": "Knoll", "year": "1996", "journal-title": "Life Sci"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB49|cit49", "doi-asserted-by": "crossref", "first-page": "1723", "DOI": "10.1038/sj.bjp.0702995", "article-title": "(-)1-(Benzofuran-2-yl)-2-propylaminopentane, [(-)BPAP], a selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain", "volume": "128", "author": "Knoll", "year": "1999", "journal-title": "Br J Pharmacol"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB50|cit50", "doi-asserted-by": "crossref", "first-page": "13402", "DOI": "10.1073/pnas.231358298", "article-title": "Positive allosteric modulators of metabotropic glutamate 1 receptor: Characterization, mechanism of action, and binding site", "volume": "98", "author": "Knoflach", "year": "2001", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB51|cit51", "doi-asserted-by": "crossref", "first-page": "539", "DOI": "10.1046/j.1468-1331.1999.650539.x", "article-title": "Does selegiline modify the progression of early Parkinson's disease? Results from a five-year study. The Norwegian-Danish Study Group", "volume": "6", "author": "Larsen", "year": "1999", "journal-title": "Eur J Neurol"}, {"issue": "Suppl", "key": "10.1111/j.1527-3458.2001.tb00202.x-BIB52|cit52", "doi-asserted-by": "crossref", "first-page": "91", "DOI": "10.1111/j.1600-0404.1991.tb05027.x", "article-title": "Selegiline hydrochloride and cognition", "volume": "136", "author": "Lees", "year": "1991", "journal-title": "Acta Neurol Scand"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB53|cit53", "doi-asserted-by": "crossref", "first-page": "1602", "DOI": "10.1136/bmj.311.7020.1602", "article-title": "Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease", "volume": "311", "author": "Lees", "year": "1995", "journal-title": "Br Med J"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB54|cit54", "doi-asserted-by": "crossref", "first-page": "100", "DOI": "10.1159/000116655", "article-title": "Effects of a MAO-B inhibitor in the treatment of Alzheimer disease", "volume": "31", "author": "Mangoni", "year": "1991", "journal-title": "Eur Neurol"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB55|cit55", "doi-asserted-by": "crossref", "first-page": "877", "DOI": "10.1016/0024-3205(80)90350-1", "article-title": "A selective monoamine oxidase-B inhibitor in endogenous depression", "volume": "26", "author": "Mann", "year": "1980", "journal-title": "Life Sci"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB56|cit56", "author": "Martin", "first-page": "813", "year": "1977", "volume-title": "Handbook of Sexology"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB57|cit57", "doi-asserted-by": "crossref", "first-page": "256", "DOI": "10.1055/s-2007-1017117", "article-title": "Brief information on an early phase-II study with (-)deprenyl in demented patients", "volume": "20", "author": "Martini", "year": "1987", "journal-title": "Pharmacopsychiatry"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB58|cit58", "doi-asserted-by": "crossref", "first-page": "415", "DOI": "10.1016/0024-3205(90)90299-7", "article-title": "Maintenance on L-(-)deprenyl prolongs life in aged male rats", "volume": "47", "author": "Milgram", "year": "1990", "journal-title": "Life Sci"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB59|cit59", "first-page": "315", "article-title": "Selegiline in the treatment of mild to moderate Alzheimer-type dementia", "volume": "12", "author": "Monteverde", "year": "1990", "journal-title": "Clin Ther"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB60|cit60", "doi-asserted-by": "crossref", "first-page": "339", "DOI": "10.1212/WNL.42.2.339", "article-title": "Selegiline as initial treatment in de novo parkinsonian patients", "volume": "42", "author": "Myttyla", "year": "1992", "journal-title": "Neurology"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB61|cit61", "doi-asserted-by": "crossref", "first-page": "1364", "DOI": "10.1056/NEJM198911163212004", "article-title": "Effect of (-)deprenyl on the progression disability in early Parkinson's disease", "volume": "321", "author": "Parkinson Study Group.", "year": "1989", "journal-title": "New Engl J Med"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB62|cit62", "doi-asserted-by": "crossref", "first-page": "176", "DOI": "10.1056/NEJM199301213280305", "article-title": "Effect to tocopherol and (-)deprenyl on the progression of disability in early Parkinson's disease", "volume": "328", "author": "Parkinson Study Group.", "year": "1993", "journal-title": "New Engl J Med"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB63|cit63", "doi-asserted-by": "crossref", "first-page": "37", "DOI": "10.1002/ana.410390107", "article-title": "Impact of deprenyl and tocopherol treatment of Parkinson's disease in DATATOP patients requiring levodopa", "volume": "39", "author": "Parkinson Study Group.", "year": "1996", "journal-title": "Ann Neurol"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB64|cit64", "doi-asserted-by": "crossref", "first-page": "739", "DOI": "10.1111/j.2042-7158.1981.tb13920.x", "article-title": "Amphetamine, p-hydroxyamphetamine and \u03b2-phenylethylamine in mouse brain and urine after (-)- and (+)-deprenyl administration", "volume": "31", "author": "Phillips", "year": "1981", "journal-title": "J Pharm Pharmacol"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB65|cit65", "doi-asserted-by": "crossref", "first-page": "147", "DOI": "10.1097/00002826-199004000-00004", "article-title": "Neuropsychological effects of L-deprenyl in Alzheimer's type dementia", "volume": "13", "author": "Piccinin", "year": "1990", "journal-title": "Clin Neuropharmacol"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB66|cit66", "doi-asserted-by": "crossref", "first-page": "209", "DOI": "10.1007/BF01246957", "article-title": "Absence of \u201ccheese effect\u201d during deprenyl therapy: Some recent studies", "volume": "43", "author": "Sandler", "year": "1978", "journal-title": "J Neural Transm"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB67|cit67", "doi-asserted-by": "crossref", "first-page": "542", "DOI": "10.1111/j.1365-2125.1978.tb00883.x", "article-title": "Deprenyl is metabolized to methamphetamine and amphetamine in man", "volume": "6", "author": "Reynolds", "year": "1978", "journal-title": "Br J Clin Pharmacol"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB68|cit68", "doi-asserted-by": "crossref", "first-page": "859", "DOI": "10.1212/WNL.41.6.859", "article-title": "Selegiline (deprenyl) treatment and death of nigral neurons in Parkinson's disease", "volume": "41", "author": "Rinne", "year": "1991", "journal-title": "Neurology"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB69|cit69", "doi-asserted-by": "crossref", "first-page": "1037", "DOI": "10.1016/S0024-3205(97)00611-5", "article-title": "Treatment with L-deprenyl prolongs life in elderly dogs", "volume": "61", "author": "Ruehl", "year": "1997", "journal-title": "Life Sci"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB70|cit70", "doi-asserted-by": "crossref", "first-page": "132", "DOI": "10.1097/00002093-199601030-00004", "article-title": "and Members of the Alzheimer's disease Cooperative Study. Rationale and design of a multicenter study of selegiline and \u03b1-tocopherol in the treatment of Alzheimer disease using novel clinical outcomes", "volume": "10", "author": "Sano", "year": "1996", "journal-title": "Alzheimer Dis Assoc Disord"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB71|cit71", "doi-asserted-by": "crossref", "first-page": "1216", "DOI": "10.1056/NEJM199704243361704", "article-title": "A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease", "volume": "336", "author": "Sano", "year": "1997", "journal-title": "New Engl J Med"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB72|cit72", "first-page": "143", "article-title": "A pilot study of low-dose L-deprenyl in Alzheimer's disease", "volume": "4", "author": "Schneider", "year": "1991", "journal-title": "J Geriatr Psychiatry Neurol"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB73|cit73", "doi-asserted-by": "crossref", "first-page": "205", "DOI": "10.1016/S0197-4580(97)00009-2", "article-title": "Chronic treatment of Syrian hamsters with low-dose selegiline increases lifespan in females but not males", "volume": "18", "author": "Stoll", "year": "1997", "journal-title": "Neurobiol Aging"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB74|cit74", "doi-asserted-by": "crossref", "first-page": "1589", "DOI": "10.1016/S0006-2952(00)00282-3", "article-title": "Protective effect of L-deprenyl against apoptosis induced by okadaic acid in cultured neuronal cells", "volume": "59", "author": "Suuronen", "year": "2000", "journal-title": "Biochem Pharmacol"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB75|cit75", "doi-asserted-by": "crossref", "first-page": "427", "DOI": "10.1001/archpsyc.1987.01800170041007", "article-title": "L-(-)deprenyl in Alzheimer's disease", "volume": "44", "author": "Tariot", "year": "1987", "journal-title": "Arch Gen Psychiatry"}, {"issue": "Suppl", "key": "10.1111/j.1527-3458.2001.tb00202.x-BIB76|cit76", "doi-asserted-by": "crossref", "first-page": "S22", "DOI": "10.1177/112067219900901S10", "article-title": "Apoptotic mechanisms in neurodegeneration: Possible relevance to glaucoma", "volume": "9", "author": "Tatton", "year": "1999", "journal-title": "Eur J Ophthal mol"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB77|cit77", "doi-asserted-by": "crossref", "first-page": "519", "DOI": "10.1126/science.2502843", "article-title": "The effect of (-)deprenyl (selegiline) on the natural history of Parkinson's disease", "volume": "245", "author": "Tetrud", "year": "1989", "journal-title": "Science"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB78|cit78", "unstructured": "Tringer L Haits G Varga E. The effect of L-E-250 (-L-phenyl-isopropylmethyl-propinyl-amine HCl) in depression V. Conferentia Hungarica pro Therapia et Investigatione in Pharmacologia Leszkovszky G Publishing House of the Hungarian Academy of Sciences 1971 111 114"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB79|cit79", "doi-asserted-by": "crossref", "first-page": "1103", "DOI": "10.1210/endo.136.3.7867565", "article-title": "Deprenyl reinitiates estrous cycles, reduces serum prolactin, and decrease the incidence of mammary and pituitary tumors in old acyclic rats", "volume": "136", "author": "ThyagaRajan", "year": "1995", "journal-title": "Endocrinology"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB80|cit80", "doi-asserted-by": "crossref", "first-page": "177", "DOI": "10.1016/S0304-3835(97)00431-X", "article-title": "Antitumor effct of L-deprenyl in rats with carcinogen-induced mammary tumors", "volume": "123", "author": "ThyagaRajan", "year": "1998", "journal-title": "Cancer Lett"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB81|cit81", "author": "Varga", "first-page": "197", "year": "1965", "volume-title": "III Conferentia Hungarica pro Therapia et Investigatione in Pharmacologia"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB82|cit82", "first-page": "289", "article-title": "Clinical trial of a new type of promptly acting psychoenergetic agent (phenyl-isopropyl-methyl-propinylamine HCl, E-250)", "volume": "23", "author": "Varga", "year": "1967", "journal-title": "Acta Med Acad Sci Hung"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB83|cit83", "doi-asserted-by": "crossref", "first-page": "113", "DOI": "10.1016/0304-3940(93)90496-8", "article-title": "Protective effect of deprenyl against 1-methyl-4-phenylpyridinium neurotoxicity in rat striatum", "volume": "152", "author": "Vizuete", "year": "1993", "journal-title": "Neurosci Lett"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB84|cit84", "doi-asserted-by": "crossref", "first-page": "241", "DOI": "10.1016/0014-2999(93)90181-G", "article-title": "Apparent antioxidant effect of l-deprenyl on hydroxyl radical formation and nigral injury elicited by MPP+", "volume": "243", "author": "Wu", "year": "1993", "journal-title": "in vivo. Eur J Pharmacol"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB85|cit85", "author": "Yasar", "first-page": "215", "year": "1993", "volume-title": "Inhibitors of Monoamine Oxidase B", "DOI": "10.1007/978-3-0348-6348-3_11", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1527-3458.2001.tb00202.x-BIB86|cit86", "first-page": "119", "article-title": "Extension of lifespan in mice treated with Dinh lang (Policias fruticosum L) and (-)deprenyl", "volume": "79", "author": "Yen", "year": "1992", "journal-title": "Acta Physiol Hung"}], "container-title": ["CNS Drug Reviews"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1527-3458.2001.tb00202.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 3, 3]], "date-time": "2019-03-03T14:41:46Z", "timestamp": 1551624106000}, "score": 42.06468, "issued": {"date-parts": [[2006, 6, 7]]}, "references-count": 86, "journal-issue": {"issue": "3"}, "URL": "http://dx.doi.org/10.1111/j.1527-3458.2001.tb00202.x", "relation": {"cites": []}, "ISSN": ["1080-563X"], "issn-type": [{"value": "1080-563X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T20:13:15Z", "timestamp": 1574107995420}, "reference-count": 27, "publisher": "Elsevier BV", "issue": "8", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1995, 1, 1]], "date-time": "1995-01-01T00:00:00Z", "timestamp": 788918400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Life Sciences"], "published-print": {"date-parts": [[1995, 1]]}, "DOI": "10.1016/0024-3205(94)00494-d", "type": "journal-article", "created": {"date-parts": [[2002, 7, 26]], "date-time": "2002-07-26T02:07:17Z", "timestamp": 1027649237000}, "page": "611-620", "source": "Crossref", "is-referenced-by-count": 39, "title": ["Enhanced catecholaminergic and serotoninergic activity in rat brain from weaning to sexual maturity: Rationale for prophylactic (-)deprenyl (selegiline) medication"], "prefix": "10.1016", "volume": "56", "author": [{"given": "Joseph", "family": "Knoll", "sequence": "first", "affiliation": []}, {"given": "Ildik\u00f3", "family": "Miklya", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Life Sciences"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:002432059400494D?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:002432059400494D?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 15]], "date-time": "2019-04-15T01:24:47Z", "timestamp": 1555291487000}, "score": 38.19565, "issued": {"date-parts": [[1995, 1]]}, "references-count": 27, "journal-issue": {"published-print": {"date-parts": [[1995, 1]]}, "issue": "8"}, "alternative-id": ["002432059400494D"], "URL": "http://dx.doi.org/10.1016/0024-3205(94)00494-d", "ISSN": ["0024-3205"], "issn-type": [{"value": "0024-3205", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T20:13:47Z", "timestamp": 1574453627258}, "reference-count": 9, "publisher": "Springer Science and Business Media LLC", "issue": "3", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2002, 9, 1]], "date-time": "2002-09-01T00:00:00Z", "timestamp": 1030838400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Eur. J. Drug Metab. Pharmacokinet."], "published-print": {"date-parts": [[2002, 9]]}, "DOI": "10.1007/bf03190451", "type": "journal-article", "created": {"date-parts": [[2010, 8, 6]], "date-time": "2010-08-06T07:30:41Z", "timestamp": 1281079841000}, "page": "157-161", "source": "Crossref", "is-referenced-by-count": 1, "title": ["The fate of (\u2212)1-(benzofuran-2-yl)-2-propylaminopentane \u00b7 HCl, (\u2212)-BPAP, in rats, a potent enhancer of the impulse-evoked release of catecholamines and serotonin in the brain"], "prefix": "10.1007", "volume": "27", "author": [{"given": "K\u00e1lm\u00e1n", "family": "Magyar", "sequence": "first", "affiliation": []}, {"given": "Joseph", "family": "Lengyel", "sequence": "additional", "affiliation": []}, {"given": "Andrea", "family": "Bolehovszky", "sequence": "additional", "affiliation": []}, {"given": "Bertha", "family": "Knoll", "sequence": "additional", "affiliation": []}, {"given": "Iidik\u00f3", "family": "Miklya", "sequence": "additional", "affiliation": []}, {"given": "Joseph", "family": "Knoll", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "BF03190451_CR1", "doi-asserted-by": "crossref", "first-page": "817", "DOI": "10.1016/0024-3205(96)00014-8", "volume": "58", "author": "J. Knoll", "year": "1996", "unstructured": "Knoll J., Miklya I., Knoll B., Mark\u00f3 R., Kelemen K. (1996): (\u2212)Deprenyl and (\u2212)1-phenyl-2-propylaminopentane, [(\u2212)PPAP], act primarily as potent stimulants of action potential- transmitter release coupling in the catecholaminergic neurones. Life Sci., 58, 817\u2013827.", "journal-title": "Life Sci."}, {"key": "BF03190451_CR2", "doi-asserted-by": "crossref", "first-page": "2101", "DOI": "10.1016/0024-3205(96)00204-4", "volume": "58", "author": "J. Knoll", "year": "1996", "unstructured": "Knoll J., Miklya I., Knoll B., Mark\u00f3 R., R\u00e1cz D. (1996): Phenylethylamine and tyramine are mixed-acting sympathomimetic amines in the brain. Life Sci., 58, 2101\u20132114.", "journal-title": "Life Sci."}, {"key": "BF03190451_CR3", "first-page": "151", "volume": "2", "author": "J. Knoll", "year": "2000", "unstructured": "Knoll J. (2000): Outlines of a drug strategy to slow brain aging. Neuropsychopharmacologia Hungarica, 2, 151\u2013170.", "journal-title": "Neuropsychopharmacologia Hungarica"}, {"key": "BF03190451_CR4", "doi-asserted-by": "crossref", "first-page": "57", "DOI": "10.1111/j.1600-0773.1998.tb01399.x", "volume": "82", "author": "J. Knoll", "year": "1998", "unstructured": "Knoll J. (1998): (\u2212)-Deprenyl (Selegiline), a catecholaminergic activity enhancer (CAE) substance acting in the brain. Pharmacol. Toxicol., 82, 57\u201366.", "journal-title": "Pharmacol. Toxicol."}, {"key": "BF03190451_CR5", "first-page": "4", "volume": "4", "author": "J. South", "year": "2001", "unstructured": "South J. (2001): Deprenyl: the anti-aging psychoenergizer. Anti-Aging Bulletin, 4, 4\u201319.", "journal-title": "Anti-Aging Bulletin"}, {"key": "BF03190451_CR6", "doi-asserted-by": "crossref", "first-page": "317", "DOI": "10.1111/j.1527-3458.2001.tb00202.x", "volume": "7", "author": "J. Knoll", "year": "2001", "unstructured": "Knoll J. (2001): Antiaging compounds: (\u2212)deprenyl (Selegiline) and (\u2212)1-(benzofuran-2-yl)-2 propylaminopentane, [(\u2212)BPAP], a selective, highly potent enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain. CNS Drug Reviews, 7, 317\u2013345.", "journal-title": "CNS Drug Reviews"}, {"key": "BF03190451_CR7", "doi-asserted-by": "crossref", "first-page": "1723", "DOI": "10.1038/sj.bjp.0702995", "volume": "128", "author": "J. Knoll", "year": "1999", "unstructured": "Knoll J., Yoneda F., Knoll B., Ohde H., Miklya I. (1999): (\u2212)1-(Benzofuran-2-yl)-2-propylaminopentane, [(\u2212)BPAP], a selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain. Br. J. Pharm., 128, 1723\u20131732.", "journal-title": "Br. J. Pharm."}, {"key": "BF03190451_CR8", "doi-asserted-by": "crossref", "first-page": "1197", "DOI": "10.1016/S0968-0896(01)00002-5", "volume": "9", "author": "F. Yoneda", "year": "2001", "unstructured": "Yoneda F., Moto M., Sakae M., Ohde H., Knoll B., Miklya I., Knoll J. (2001): Structure-activity studies leading to (\u2212)-1-(benzofuran-2-yl)-2-propylaminopentane, ((\u2212)BPAP, a highly potent, selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain. Bioorg, Med. Chem., 9, 1197\u20131212.", "journal-title": "Bioorg, Med. Chem."}, {"key": "BF03190451_CR9", "doi-asserted-by": "crossref", "first-page": "1213", "DOI": "10.1016/S0968-0896(00)00341-2", "volume": "9", "author": "T. Oka", "year": "2001", "unstructured": "Oka T., Yasusa T., Ando T., Watanabe M., Yoneda F., Ishida T., Knoll J. (2001): Enantioselective synthesis and absolute configuration of (\u2212)-1-(benzofuran-2-yl)-2-propylaminopentane, ((\u2212)BPAP, a highly potent and selective catecholaminergic activity enhancer. Bioorg. Med. Chem., 9, 1213\u20131219.", "journal-title": "Bioorg. Med. Chem."}], "container-title": ["European Journal of Drug Metabolism and Pharmacokinetics"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/BF03190451.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/BF03190451/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/BF03190451", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 22]], "date-time": "2019-05-22T03:59:36Z", "timestamp": 1558497576000}, "score": 36.135544, "issued": {"date-parts": [[2002, 9]]}, "references-count": 9, "journal-issue": {"published-print": {"date-parts": [[2002, 9]]}, "issue": "3"}, "alternative-id": ["BF03190451"], "URL": "http://dx.doi.org/10.1007/bf03190451", "relation": {"cites": []}, "ISSN": ["0378-7966", "2107-0180"], "issn-type": [{"value": "0378-7966", "type": "print"}, {"value": "2107-0180", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T08:05:13Z", "timestamp": 1574150713439}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1990, 7, 1]], "date-time": "1990-07-01T00:00:00Z", "timestamp": 646790400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Journal of Pharmacology"], "published-print": {"date-parts": [[1990, 7]]}, "DOI": "10.1016/0014-2999(90)93318-k", "type": "journal-article", "created": {"date-parts": [[2003, 1, 30]], "date-time": "2003-01-30T15:52:50Z", "timestamp": 1043941970000}, "page": "432-433", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Influence on catecholaminergic and serotonergic systems by (\u2212)deprenyl"], "prefix": "10.1016", "volume": "183", "author": [{"given": "G.", "family": "Zsilla", "sequence": "first", "affiliation": []}, {"given": "J.", "family": "Knoll", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Journal of Pharmacology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:001429999093318K?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:001429999093318K?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 3, 30]], "date-time": "2019-03-30T06:29:13Z", "timestamp": 1553927353000}, "score": 35.313892, "issued": {"date-parts": [[1990, 7]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1990, 7]]}, "issue": "2"}, "alternative-id": ["001429999093318K"], "URL": "http://dx.doi.org/10.1016/0014-2999(90)93318-k", "ISSN": ["0014-2999"], "issn-type": [{"value": "0014-2999", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T11:16:13Z", "timestamp": 1574162173008}, "reference-count": 10, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1979, 1, 1]], "date-time": "1979-01-01T00:00:00Z", "timestamp": 283996800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Trends in Neurosciences"], "published-print": {"date-parts": [[1979, 1]]}, "DOI": "10.1016/0166-2236(79)90044-4", "type": "journal-article", "created": {"date-parts": [[2003, 4, 25]], "date-time": "2003-04-25T10:23:44Z", "timestamp": 1051266224000}, "page": "111-113", "source": "Crossref", "is-referenced-by-count": 12, "title": ["(-)Deprenyl \u2014 the MAO inhibitor without the \u2018cheese effect\u2019"], "prefix": "10.1016", "volume": "2", "author": [{"given": "Joseph", "family": "Knoll", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Trends in Neurosciences"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:0166223679900444?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:0166223679900444?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 3, 22]], "date-time": "2019-03-22T05:24:50Z", "timestamp": 1553232290000}, "score": 32.019833, "issued": {"date-parts": [[1979, 1]]}, "references-count": 10, "alternative-id": ["0166223679900444"], "URL": "http://dx.doi.org/10.1016/0166-2236(79)90044-4", "ISSN": ["0166-2236"], "issn-type": [{"value": "0166-2236", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T12:37:40Z", "timestamp": 1574167060537}, "reference-count": 31, "publisher": "Wiley", "issue": "8", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 5753, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1999, 12]]}, "DOI": "10.1038/sj.bjp.0702995", "type": "journal-article", "created": {"date-parts": [[2005, 1, 28]], "date-time": "2005-01-28T20:29:41Z", "timestamp": 1106944181000}, "page": "1723-1732", "source": "Crossref", "is-referenced-by-count": 35, "title": ["(\u2212)1-(Benzofuran-2-yl)-2-propylaminopentane, [(\u2212)BPAP], a selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain"], "prefix": "10.1111", "volume": "128", "author": [{"given": "Joseph", "family": "Knoll", "sequence": "first", "affiliation": []}, {"given": "Fumio", "family": "Yoneda", "sequence": "additional", "affiliation": []}, {"given": "Berta", "family": "Knoll", "sequence": "additional", "affiliation": []}, {"given": "Hironori", "family": "Ohde", "sequence": "additional", "affiliation": []}, {"given": "Ildik\u00f3", "family": "Miklya", "sequence": "additional", "affiliation": []}], "member": "311", "reference": [{"key": "10.1038/sj.bjp.0702995-BIB1", "doi-asserted-by": "crossref", "first-page": "B448", "DOI": "10.1093/gerona/51A.6.B448", "article-title": "L-Deprenyl treatment in aged mice slightly increases life spans, and greatly reduces fecundity by aged males", "volume": "31A", "author": "ARCHER", "year": "1996", "journal-title": "J. Gerontol. Biol. Sci."}, {"key": "10.1038/sj.bjp.0702995-BIB2", "first-page": "181", "article-title": "Is there a \u2018non-MAO\u2019 macromolecular target for L-deprenyl?: Studies on MAOB mutant mice", "volume": "63", "author": "EKBLOM", "year": "1998", "journal-title": "Life Sci."}, {"key": "10.1038/sj.bjp.0702995-BIB3", "unstructured": "HOFFMAN, B.B. & LEFKOWITZ, R.J. (1996). Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists. In: Hardman, J.G. & Limbird, L.E. (eds). Goodman and Gilman's The Pharmacological Basis of Therapeutics, Ninth edition. New York: McGraw-Hill pp. 199-248."}, {"key": "10.1038/sj.bjp.0702995-BIB4", "first-page": "431", "article-title": "Chronic treatment of aged mice with L-deprenyl produced marked MAO-B inhibition but no beneficial effects on survival, motor performance, or nigral lipofuscin accumulation", "volume": "14", "author": "INGRAM", "year": "1993", "journal-title": "Neurobiol. Aging"}, {"key": "10.1038/sj.bjp.0702995-BIB5", "first-page": "291", "article-title": "Assessing the effects of deprenyl on longevity and antioxidant defenses in different animal models", "volume": "854", "author": "KITANI", "year": "1998", "journal-title": "Ann. N.Y. Acad. Sci."}, {"key": "10.1038/sj.bjp.0702995-BIB6", "first-page": "281", "article-title": "Chronic treatment of (\u2212)deprenyl prolongs the life span of male Fischer 344 rats: Further evidence", "volume": "52", "author": "KITANI", "year": "1993", "journal-title": "Life Sci."}, {"key": "10.1038/sj.bjp.0702995-BIB7", "author": "KNOLL", "year": "1969"}, {"key": "10.1038/sj.bjp.0702995-BIB8", "first-page": "237", "article-title": "The striatal dopamine dependency of lifespan in male rats. Longevity study with (\u2212)deprenyl", "volume": "46", "author": "KNOLL", "year": "1988", "journal-title": "Mech. Ageing Dev."}, {"key": "10.1038/sj.bjp.0702995-BIB9", "first-page": "65", "article-title": "Memories of my 45 years in research", "volume": "75", "author": "KNOLL", "year": "1994", "journal-title": "Pharmacol. Toxicol."}, {"key": "10.1038/sj.bjp.0702995-BIB10", "first-page": "539", "article-title": "Sexual performance and longevity", "volume": "32", "author": "KNOLL", "year": "1997", "journal-title": "Exp. Gerontol."}, {"key": "10.1038/sj.bjp.0702995-BIB11", "first-page": "57", "article-title": "(\u2212)Deprenyl (Selegiline) a catecholaminergic activity enhancer (CAE) substance acting in the brain", "volume": "82", "author": "KNOLL", "year": "1998", "journal-title": "Pharm. Toxicol."}, {"key": "10.1038/sj.bjp.0702995-BIB12", "first-page": "525", "article-title": "Striatal dopamine, sexual activity and lifespan. Longevity of rats treated with (\u2212)deprenyl", "volume": "45", "author": "KNOLL", "year": "1989", "journal-title": "Life Sci."}, {"key": "10.1038/sj.bjp.0702995-BIB13", "first-page": "154", "article-title": "Phenylisopropylmethylpropinylamine (E-250) a new psychic energizer", "volume": "155", "author": "KNOLL", "year": "1965", "journal-title": "Arch. Int. Pharmacodyn. Th\u00e9r."}, {"key": "10.1038/sj.bjp.0702995-BIB14", "first-page": "5", "article-title": "The pharmacology of 1-phenyl-2-propylaminopentane (PPAP), a deprenyl-derived new spectrum psychostimulant", "volume": "316", "author": "KNOLL", "year": "1992", "journal-title": "Arch. Int. Pharmacodyn. Th\u00e9r."}, {"key": "10.1038/sj.bjp.0702995-BIB15", "first-page": "393", "article-title": "Some puzzling effects of monoamine oxidase inhibitors", "volume": "5", "author": "KNOLL", "year": "1972", "journal-title": "Adv. Bioch. Psychopharmacol."}, {"key": "10.1038/sj.bjp.0702995-BIB16", "first-page": "1", "article-title": "Multiple, small dose administration of (\u2212)deprenyl enhances catecholaminergic activity and diminishes serotoninergic activity in the brain and these effects are unrelated to MAO-B inhibition", "volume": "328", "author": "KNOLL", "year": "1994", "journal-title": "Arch. Int. Pharmacodyn. Th\u00e9r."}, {"key": "10.1038/sj.bjp.0702995-BIB17", "first-page": "611", "article-title": "Enhanced catecholaminergic and serotoninergic activity in rat brain from weaning to sexual maturity. Rationale for prophylactic (\u2212)deprenyl (selegiline) medication", "volume": "56", "author": "KNOLL", "year": "1995", "journal-title": "Life Sci."}, {"key": "10.1038/sj.bjp.0702995-BIB18", "first-page": "817", "article-title": "(\u2212)Deprenyl and (\u2212)1-phenyl-2-propylaminopentane [(\u2212)PPAP], act primarily as potent stimulants of action potential-transmitter release coupling in the catecholaminergic neurons", "volume": "58", "author": "KNOLL", "year": "1996", "journal-title": "Life Sci."}, {"key": "10.1038/sj.bjp.0702995-BIB19", "first-page": "2101", "article-title": "Phenylethylamine and tyramine are mixed-acting sympathomimetic amines in the brain", "volume": "58", "author": "KNOLL", "year": "1996", "journal-title": "Life Sci."}, {"key": "10.1038/sj.bjp.0702995-BIB20", "first-page": "1047", "article-title": "Sexually low performing male rats die earlier than their high performing peers and (\u2212)deprenyl treatment eliminates this difference", "volume": "54", "author": "KNOLL", "year": "1994", "journal-title": "Life Sci."}, {"key": "10.1038/sj.bjp.0702995-BIB21", "first-page": "877", "article-title": "A selective monoamine oxidase-B inhibitor in endogenous depression", "volume": "26", "author": "MANN", "year": "1980", "journal-title": "Life Sci."}, {"key": "10.1038/sj.bjp.0702995-BIB22", "first-page": "415", "article-title": "Maintenance on L-deprenyl prolongs life in aged male rats", "volume": "47", "author": "MILGRAM", "year": "1990", "journal-title": "Life Sci."}, {"key": "10.1038/sj.bjp.0702995-BIB23", "unstructured": "PARKINSON STUDY GROUP. (1989). Effect of (\u2212)deprenyl on the progression disability in early Parkinson's disease. New Engl. J. Med., 321, 1364-1371."}, {"key": "10.1038/sj.bjp.0702995-BIB24", "first-page": "1037", "article-title": "Treatment with L-deprenyl prolongs life in elderly dogs", "volume": "61", "author": "RUEHL", "year": "1997", "journal-title": "Life Sci."}, {"key": "10.1038/sj.bjp.0702995-BIB25", "first-page": "1216", "article-title": "A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease", "volume": "336", "author": "SANO", "year": "1997", "journal-title": "New Engl. J. Med."}, {"key": "10.1038/sj.bjp.0702995-BIB26", "first-page": "205", "article-title": "Chronic treatment of Syrian hamsters with low-dose selegiline increases life span in females but not males", "volume": "18", "author": "STOLL", "year": "1997", "journal-title": "Neurobiol. Aging"}, {"key": "10.1038/sj.bjp.0702995-BIB27", "first-page": "666", "article-title": "Rescue of dying neurons: a new action for deprenyl in MPTP parkinsonism", "volume": "30", "author": "TATTON", "year": "1991", "journal-title": "J. Neurosci. Res."}, {"key": "10.1038/sj.bjp.0702995-BIB28", "first-page": "519", "article-title": "The effect of (\u2212)deprenyl (selegiline) on the natural history of Parkinson's disease", "volume": "245", "author": "TETRUD", "year": "1989", "journal-title": "Science"}, {"key": "10.1038/sj.bjp.0702995-BIB29", "first-page": "361", "article-title": "Determination of monoamine oxidase", "volume": "7", "author": "TIPTON", "year": "1985", "journal-title": "Meth. Find. Exptl. Clin. Pharmacol."}, {"key": "10.1038/sj.bjp.0702995-BIB30", "first-page": "289", "article-title": "Clinical trial of a new type of promptly acting psychoenergetic agent (phenyl-isopropylmethyl-propinylamine HCl, E-250)", "volume": "23", "author": "VARGA", "year": "1967", "journal-title": "Acta Med. Acad. Sci. Hung."}, {"key": "10.1038/sj.bjp.0702995-BIB31", "first-page": "147", "article-title": "Ultrastructural analysis of \u03b2-amyloid-induced apoptosis in cultured hippocampal neurons", "volume": "661", "author": "WATT", "year": "1994", "journal-title": "Brain Res."}], "container-title": ["British Journal of Pharmacology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1038%2Fsj.bjp.0702995", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 16]], "date-time": "2017-06-16T15:14:35Z", "timestamp": 1497626075000}, "score": 31.587223, "issued": {"date-parts": [[1999, 12]]}, "references-count": 31, "journal-issue": {"published-print": {"date-parts": [[1999, 12]]}, "issue": "8"}, "URL": "http://dx.doi.org/10.1038/sj.bjp.0702995", "relation": {"cites": []}, "ISSN": ["0007-1188", "1476-5381"], "issn-type": [{"value": "0007-1188", "type": "print"}, {"value": "1476-5381", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T19:31:17Z", "timestamp": 1574278277177}, "reference-count": 106, "publisher": "Wiley", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 11750, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1983, 7]]}, "DOI": "10.1111/j.1600-0404.1983.tb01517.x", "type": "journal-article", "created": {"date-parts": [[2009, 1, 31]], "date-time": "2009-01-31T16:13:30Z", "timestamp": 1233418410000}, "page": "57-80", "source": "Crossref", "is-referenced-by-count": 108, "title": ["Deprenyl (selegiline): the history of its development and pharmacological action"], "prefix": "10.1111", "volume": "68", "author": [{"given": "J.", "family": "KNOLL", "sequence": "first", "affiliation": []}], "member": "311", "reference": [{"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB1", "doi-asserted-by": "crossref", "first-page": "349", "DOI": "10.1007/BF02174413", "article-title": "Influence of isonicotinic acid hydrazide (INH) and 1-isonicotinic-2-isopropyl hydrazide (IIH) on bacterial and mammalian enzymes", "volume": "8", "author": "Zeller", "year": "1952", "journal-title": "Experientia"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB2", "doi-asserted-by": "crossref", "first-page": "849", "DOI": "10.1016/S0140-6736(63)92743-0", "article-title": "Hypertensive crisis due to monoamine oxidase inhibitors", "volume": "II", "author": "Blackwell", "year": "1963", "journal-title": "Lancet"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB3", "doi-asserted-by": "crossref", "first-page": "463", "DOI": "10.1016/S0140-6736(63)92211-6", "article-title": "Tranylcypromine", "volume": "II", "author": "Womack", "year": "1963", "journal-title": "Lancet"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB4", "doi-asserted-by": "crossref", "first-page": "366", "DOI": "10.1136/bmj.2.5353.366", "article-title": "Sudden death during treatment with tranylcypromine", "volume": "II", "author": "Womack", "year": "1963", "journal-title": "Brit med J"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB5", "doi-asserted-by": "crossref", "first-page": "587", "DOI": "10.1016/S0140-6736(63)92679-5", "article-title": "Tranylcypromine and cheese", "volume": "II", "author": "Foster", "year": "1963", "journal-title": "Lancet"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB6", "doi-asserted-by": "crossref", "first-page": "639", "DOI": "10.1016/S0140-6736(63)90428-8", "article-title": "Tranylcypromine and cheese", "volume": "II", "author": "Maan", "year": "1963", "journal-title": "Lancet"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB7", "doi-asserted-by": "crossref", "first-page": "691", "DOI": "10.1016/S0140-6736(63)90489-6", "article-title": "Tranylcypromine and cheese", "volume": "II", "author": "Davies", "year": "1963", "journal-title": "Lancet"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB8", "doi-asserted-by": "crossref", "first-page": "733", "DOI": "10.1016/S0140-6736(63)90368-4", "article-title": "Tranylcypromine and cheese", "volume": "II", "author": "Asatoor", "year": "1963", "journal-title": "Lancet"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB9", "doi-asserted-by": "crossref", "first-page": "1108", "DOI": "10.1001/jama.1964.03060390010002", "article-title": "Monoamine oxidase inhibitors, tyramine and cheese", "volume": "188", "author": "Horwitz", "year": "1964", "journal-title": "JAMA"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB10", "doi-asserted-by": "crossref", "first-page": "2051", "DOI": "10.1001/jama.1935.02760510023006", "article-title": "The use of benzedrine for the treatment of narcolepsy", "volume": "105", "author": "Prinzmetal", "year": "1935", "journal-title": "JAMA"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB11", "first-page": "442", "article-title": "Psychoniimetic methylamphetamine derivatives", "volume": "159", "author": "Knoll", "year": "1966", "journal-title": "Arch int Pharmacodyn"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB12", "author": "Knoll", "first-page": "761", "year": "1970", "volume-title": "Amphetamines and Related Compounds"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB13", "doi-asserted-by": "crossref", "first-page": "67", "DOI": "10.1016/S0031-6989(70)80036-4", "article-title": "Inhibition of the effects of LSD and p-bromo-methamphetamine (V-111) by p-chlorophenylalanine", "volume": "2", "author": "Knoll", "year": "1970", "journal-title": "Pharm Res Comm"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB14", "doi-asserted-by": "crossref", "first-page": "278", "DOI": "10.1159/000136148", "article-title": "Cross tolerance between para-bromomethamphetamine (V-III) and LSD-25", "volume": "4", "author": "Knoll", "year": "1970", "journal-title": "Pharmacology"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB15", "first-page": "151", "article-title": "Pharmacological studies on parabromo-methamphetamine (V-III) and LSD", "volume": "37", "author": "Knoll", "year": "1970", "journal-title": "Acta Physiol Hung"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB16", "author": "Knoll", "first-page": "167", "year": "1972", "volume-title": "Recent Developments of Neurobiology in Hungary. III. Results in Neuropharmacology"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB17", "author": "Knoll", "first-page": "55", "year": "1973", "volume-title": "Pharmacology and the Future of Man"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB18", "first-page": "198", "article-title": "p-Bromo-methamphetamines. (V-III) induced improvement of learning ability in rats", "volume": "10", "author": "Knoll", "year": "1975", "journal-title": "Int J Neurology"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB19", "doi-asserted-by": "crossref", "first-page": "2071", "DOI": "10.1016/0006-2952(80)90493-1", "article-title": "Inhibition of monoamine oxidase by d-methamphetamine", "volume": "29", "author": "Suzuki", "year": "1980", "journal-title": "Biochem Pharmac"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB20", "first-page": "231", "article-title": "Phenylisopropylmethyl-propinylamine HCl (E-250) egy uj hat\u00e1sspektrumu pszichoenergetikum. MTA V. Oszt", "volume": "15", "author": "Knoll", "year": "1964", "journal-title": "K\u00f6zl."}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB21", "first-page": "154", "article-title": "Phenylisopropylmethyl-propinylamine (E-250), a new psychic energizer", "volume": "155", "author": "Knoll", "year": "1965", "journal-title": "Arch int Pharmacodyn"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB22", "first-page": "33", "article-title": "A phenylisopropyl-methylpropinylamine (E-250) tyraminantagonista hat\u00e5sa. MTA V. Oszt", "volume": "18", "author": "Knoll", "year": "1967", "journal-title": "K\u00f6zl."}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB23", "first-page": "109", "article-title": "Phenylisopro-pylmethylpropinylamine (E-250), a monoamine oxidase inhibitor antagonizing effects of tyramine", "volume": "18", "author": "Knoll", "year": "1968", "journal-title": "Arzneim.-Forsch."}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB24", "doi-asserted-by": "crossref", "first-page": "1285", "DOI": "10.1016/0006-2952(68)90066-X", "article-title": "Some observations upon a new inhibitor of monoamine oxidase in brain tissue", "volume": "17", "author": "Johnston", "year": "1968", "journal-title": "Biochem Pharmacol"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB25", "first-page": "2097", "article-title": "Kinetic studies and in vivo effects of a new monoamine oxidase inhibitor N-/2-(o-chlorophenoxy)-ethyl/-cyclopropylamine. Biochem", "volume": "17", "author": "Fuller", "year": "1968", "journal-title": "Pharmacol."}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB26", "doi-asserted-by": "crossref", "first-page": "2301", "DOI": "10.1016/0024-3205(65)90253-5", "article-title": "Two types of monoamine liberation by chlorinated aralkylamines", "volume": "4", "author": "Pletscher", "year": "1965", "journal-title": "Life Sci"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB27", "author": "Strolin", "first-page": "82", "year": "1983", "volume-title": "Monoamine Oxidase and Its Selective Inhibitors (Modern Problems of Pharmacopsychiatry"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB28", "doi-asserted-by": "crossref", "first-page": "1447", "DOI": "10.1016/0006-2952(69)90258-5", "article-title": "Further studies on the inhibition of monoamine oxid\u00e5se by MB 9302 (Clorgyline). I Substrate specificity in various mammalian species", "volume": "18", "author": "Hall", "year": "1969", "journal-title": "Biochem Pharmacol"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB29", "first-page": "393", "article-title": "Some puzzling effects of monoamine oxidase inhibitors", "volume": "5", "author": "Knoll", "year": "1972", "journal-title": "Adv Biochem Psychopharmacol"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB30", "doi-asserted-by": "crossref", "first-page": "919", "DOI": "10.1016/0006-2952(79)90376-9", "article-title": "Does the B form selective monoamine oxidase inhibitor lose selectivity by long term treatment", "volume": "28", "author": "Ekstedt", "year": "1979", "journal-title": "Biochem Pharmacol"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB31", "first-page": "355", "article-title": "Multiple forms of monoamine oxidase in intact mitochondria as characterized by selective inhibitors and thermal stability: a comparison of eight mammalian species", "volume": "5", "author": "Squires", "year": "1972", "journal-title": "Adv Biochem Psychopharmacol"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB32", "author": "Magyar", "first-page": "107", "year": "1973", "volume-title": "Selective inhibition of monoamine oxidase by Deprenyl"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB33", "author": "Knoll", "first-page": "131", "year": "1976", "volume-title": "Monoamine Oxidase and Its inhibition"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB34", "doi-asserted-by": "crossref", "first-page": "177", "DOI": "10.1007/BF01246955", "article-title": "The possible mechanism of action of (-)deprenyl in Parkinson's disease", "volume": "43", "author": "Knoll", "year": "1978", "journal-title": "J Neural Transm"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB35", "doi-asserted-by": "crossref", "first-page": "33", "DOI": "10.1007/BF00426954", "article-title": "Deprenyl administration in man: A selective monoamine oxidase B in hibitor without the \u201ccheese effect\u201d", "volume": "57", "author": "Elsworth", "year": "1978", "journal-title": "Psycho-pharmacology"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB36", "doi-asserted-by": "crossref", "first-page": "209", "DOI": "10.1007/BF01246957", "article-title": "Absence of \u201ccheese effect\u201d during deprenyl therapy: some recent studies", "volume": "43", "author": "Sandler", "year": "1978", "journal-title": "J. Neural Transmission"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB37", "unstructured": "37. Pare C M B , Sandler M , Stern G. Clinical usefulness of Deprenyl - a new MAO in hibitor. Abstr. 11th CINP Congress Vienna, 1978: 286."}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB38", "author": "Mendis", "first-page": "171", "year": "1981", "volume-title": "Monoamine Oxidase Inhibitors. The State of the Art"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB39", "doi-asserted-by": "crossref", "first-page": "1317", "DOI": "10.1016/S0140-6736(75)92319-3", "article-title": "Intravenous tyramine pressor response in depression", "volume": "I", "author": "Ghose", "year": "1975", "journal-title": "Lancet"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB40", "doi-asserted-by": "crossref", "first-page": "560", "DOI": "10.1007/BF00343235", "article-title": "Der L-3, 4-Dioxyphenylalanin (= Dopa)- Effekt beim Parkinson-Syndrom des Menschen", "volume": "203", "author": "Birkmayer", "year": "1962", "journal-title": "Arch Psychiat Nervenkr"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB41", "doi-asserted-by": "crossref", "first-page": "439", "DOI": "10.1016/S0140-6736(77)91940-7", "article-title": "Implications of combined treatment with Madopar and 1-deprenyl in Parkinson's disease", "volume": "II", "author": "Birkmayer", "year": "1977", "journal-title": "Lancet"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB42", "author": "Birkmayer", "year": "1980", "volume-title": "Die Parkinson-Krankheit. Biochemie, Klinik, Therapie", "DOI": "10.1007/978-3-7091-2253-2", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB43", "year": "1980", "unstructured": "43. MagyarK, ed. Monoamine Oxidases and Their Selective Inhibitors. Budapest: Pergamon Press-Akad\u00e9miai Kiad\u00f3, 1980.", "volume-title": "Monoamine Oxidases and Their Selective Inhibitors"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB44", "year": "1983", "unstructured": "44. BeckmannH, RiedererP, eds. Monoamine Oxidase and Its Selective Inhibitors (Modern Problems of Pharmacopsychiatry, Vol. 19), Basel: S Karger, 1983.", "volume-title": "Monoamine Oxidase and Its Selective Inhibitors (Modern Problems of Pharmacopsychiatry"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB45", "doi-asserted-by": "crossref", "first-page": "806", "DOI": "10.1016/0006-2952(77)90233-7", "article-title": "Interaction of selective inhibitors of monoamine oxidase with pethidine in rabbits", "volume": "26", "author": "Jounela", "year": "1977", "journal-title": "Biochemical Pharmacology"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB46", "doi-asserted-by": "crossref", "first-page": "456", "DOI": "10.1001/jama.1964.03070180054008", "article-title": "Monoamine oxidase inhibitors. Adverse reactions and possible mechanisms", "volume": "190", "author": "Goldberg", "year": "1964", "journal-title": "JAMA"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB47", "doi-asserted-by": "crossref", "first-page": "80", "DOI": "10.1038/265080a0", "article-title": "Dopamine is a monoamine oxidase B substrate in man", "volume": "265", "author": "Glover", "year": "1977", "journal-title": "Nature"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB48", "author": "Zsilla", "first-page": "211", "year": "1982", "volume-title": "Typical and Atypical Antidepressants: Molecular Mechanisms"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB49", "author": "Knoll", "first-page": "45", "year": "1981", "volume-title": "Monoamine Oxidase Inhibitors - the State of the Art"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB50", "author": "Knoll", "first-page": "107", "year": "1982", "volume-title": "Strategy in Drug Research"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB51", "author": "Knoll", "year": "1983", "volume-title": "Movement Disorder"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB52", "author": "Magyar", "first-page": "103", "year": "1971", "volume-title": "V. Conferentia Hungarica pro Therapia et Investigatione in Pharmacologia"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB53", "doi-asserted-by": "crossref", "first-page": "223", "DOI": "10.1007/BF01248954", "article-title": "Effects of 1-deprenyl on human growth hormone secretion", "volume": "51", "author": "Koulu", "year": "1981", "journal-title": "J Neural Transm"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB54", "doi-asserted-by": "crossref", "first-page": "303", "DOI": "10.1007/BF01253131", "article-title": "The potentiation of the antiakinetic effect after L-Dopa treatment by an inhibitor of MAO-B, Deprenil", "volume": "36", "author": "Birkmayer", "year": "1975", "journal-title": "J Neural Transm"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB55", "unstructured": "55. Lees A J , Shaw K M , Kohout L J , Stern G M , Elsworth J D , Sandler M , Youdim M B H. Deprenyl in Parkinson's disease. Lancet 1977: 791-796.", "DOI": "10.1016/S0140-6736(77)90725-5", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB56", "doi-asserted-by": "crossref", "first-page": "263", "DOI": "10.1007/BF01246963", "article-title": "Experiences with L-Deprenyl in Parkinsonism", "volume": "43", "author": "Csanda", "year": "1978", "journal-title": "J Neural Transm"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB57", "author": "Csanda", "first-page": "127", "year": "1980", "volume-title": "Monoamine Oxidases and Their Selective Inhibitors", "DOI": "10.1016/B978-0-08-026389-2.50022-6", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB58", "doi-asserted-by": "crossref", "first-page": "253", "DOI": "10.1007/BF01246962", "article-title": "L-Deprenyl treatment of on-off phenomena in Parkinson's disease", "volume": "43", "author": "Rinne", "year": "1978", "journal-title": "J Neural Transm"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB59", "author": "Rinne", "first-page": "145", "year": "1980", "volume-title": "Monoamine Oxidases and Their Selective Inhibition", "DOI": "10.1016/B978-0-08-026389-2.50025-1", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB60", "doi-asserted-by": "crossref", "first-page": "245", "DOI": "10.1007/BF01246961", "article-title": "Recent observations on the clinical pharmacology of (-)deprenyl", "volume": "43", "author": "Stern", "year": "1978", "journal-title": "J Neural Transm"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB61", "author": "Stern", "first-page": "324", "year": "1982", "volume-title": "Rose and Capildeo Research Progress in Parkinson's Disease"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB62", "doi-asserted-by": "crossref", "first-page": "227", "DOI": "10.1007/BF01246959", "article-title": "Overview of present day treatment of Parkinson's disease", "volume": "48", "author": "Yahr", "year": "1978", "journal-title": "J Neural Transm"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB63", "author": "Yahr", "first-page": "117", "year": "1980", "volume-title": "Monoamine Oxidases and Their Selective Inhibition", "DOI": "10.1016/B978-0-08-026389-2.50021-4", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB64", "author": "Wajsbort", "first-page": "139", "year": "1980", "volume-title": "Monoamine Oxidases and Their Selective Inhibition", "DOI": "10.1016/B978-0-08-026389-2.50024-X", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB65", "author": "Barbeau", "first-page": "229", "year": "1980", "volume-title": "Parkinson's Disease. Current Progress, Problems and Management"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB66", "unstructured": "66. Lancet Editorial. Deprenyl in Parkinson's disease. September 1982."}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB67", "author": "Birkmayer", "first-page": "170", "year": "1983", "volume-title": "Monoamine Oxidase and Its Selective Inhibitors (Modern Problems in Pharmacopsychiatry"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB68", "doi-asserted-by": "crossref", "first-page": "277", "DOI": "10.1007/BF01249445", "article-title": "Time course of nigrostriatal degeneration in Parkinson's disease", "volume": "38", "author": "Riederer", "year": "1976", "journal-title": "J Neural Transm"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB69", "author": "Birkmayer", "year": "1979", "volume-title": "The extrapyramidal System and its Disorders (Advances in Neurology"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB70", "author": "Riederer", "first-page": "154", "year": "1983", "volume-title": "Monoamine Oxidase and Its Selective Inhibitors (Modern Problems in Pharmacopsychiatry"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB71", "first-page": "66", "article-title": "A multiple-dose controlled study of phenelzine in depression-anxiety states", "volume": "30", "author": "Ravaris", "year": "1976", "journal-title": "Arch Gen Psychiatry"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB72", "doi-asserted-by": "crossref", "first-page": "70", "DOI": "10.1097/00004714-198103000-00005", "article-title": "Monoamine oxidase inhibitors in bipolar endogenous depressives", "volume": "1", "author": "Quitkin", "year": "1981", "journal-title": "J Clin Psychopharmacology"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB73", "doi-asserted-by": "crossref", "first-page": "382", "DOI": "10.1176/ajp.137.3.382-a", "article-title": "Treating depression with amphetamines", "volume": "137", "author": "Ostow", "year": "1980", "journal-title": "Am J Psychiatry"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB74", "first-page": "289", "article-title": "Clinical trial of a new type of promptly acting psychoenergetic agent (phenyl-isopropyl-methyl-propinylamine. HCl) (E-250)", "volume": "23", "author": "Varga", "year": "1967", "journal-title": "Acta Med Acad Sci Hung"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB75", "first-page": "377", "article-title": "Comparative pharmacological analysis of the optical isomers of phenyl-isopropyl-methyl-pro-pinylamine (E-250)", "volume": "32", "author": "Magyar", "year": "1967", "journal-title": "Acta Physiol Hung"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB76", "author": "Tringer", "first-page": "111", "year": "1971", "volume-title": "The effect of 1-E-250 (l-phenyl-isopropylmethyl-propinylamine (HCl) in depressions"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB77", "doi-asserted-by": "crossref", "first-page": "877", "DOI": "10.1016/0024-3205(80)90350-1", "article-title": "L-deprenyl, a selective monoamine oxidase type B inhibitor in endogenous depression", "volume": "26", "author": "Mann", "year": "1980", "journal-title": "Life Sciences"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB78", "doi-asserted-by": "crossref", "first-page": "54", "DOI": "10.1097/00004714-198202000-00008", "article-title": "The relative efficacy of l-deprenyl, a selective monoamine oxidase type B inhibitor, in endogenous and non-endogenous depression", "volume": "2", "author": "Mann", "year": "1982", "journal-title": "J Clin Psychopharmacology"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB79", "doi-asserted-by": "crossref", "first-page": "279", "DOI": "10.1007/BF01246965", "article-title": "Anti-depressant potentiation of 5-hydroxytryptophan by l-deprenyl, an MAO \u201ctype B\u201d inhibitor", "volume": "43", "author": "Mendlewicz", "year": "1978", "journal-title": "J Neural Transm"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB80", "doi-asserted-by": "crossref", "first-page": "257", "DOI": "10.1016/0006-2952(78)90226-5", "article-title": "Mode of action of antidepressant drugs", "volume": "27", "author": "Sulser", "year": "1978", "journal-title": "Biochem Pharmac"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB81", "doi-asserted-by": "crossref", "first-page": "289", "DOI": "10.1016/0014-2999(80)90510-5", "article-title": "Down regulation of dihydroalprenolol and imipramine binding sites in brain of rats repeatedly treated with imipramine", "volume": "67", "author": "Kinnier", "year": "1980", "journal-title": "Eur J Pharmacol"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB82", "doi-asserted-by": "crossref", "first-page": "88", "DOI": "10.1126/science.6251550", "article-title": "Long-term antidepressant treatment decreases spiroperidol labeled serotonin receptor binding", "volume": "210", "author": "Peroutka", "year": "1980", "journal-title": "Science"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB83", "first-page": "303", "article-title": "Serotonin receptor sensitivity after acute and chronic treatment with mianserin. J Pharmacol", "volume": "221", "author": "Blackshear", "year": "1982", "journal-title": "Exp Ther"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB84", "doi-asserted-by": "crossref", "first-page": "495", "DOI": "10.1038/257495a0", "article-title": "Action of various antidepressant treatment reduces reactivity of noradrenergic cyclic AMP generating system in limbic forebrain", "volume": "257", "author": "Vetulani", "year": "1975", "journal-title": "Nature"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB85", "author": "Brunello", "first-page": "179", "year": "1982", "volume-title": "Typical and Atypical Antidepressants from Molecular Mechanisms to Clinical Practice"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB86", "doi-asserted-by": "crossref", "first-page": "749", "DOI": "10.1001/archpsyc.1979.01780070027003", "article-title": "Monoamine oxidase inhibitors: a review of antidepressant effectiveness", "volume": "36", "author": "Quitkin", "year": "1979", "journal-title": "Arch Gen Psychiatry"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB87", "doi-asserted-by": "crossref", "first-page": "111", "DOI": "10.1016/0014-2999(83)90614-3", "article-title": "(-)Deprenyl a selective MAO \u201cB\u201d inhibitor increases (3H)impiramine binding and decreases \u03b2-adrenergic receptor function", "volume": "89", "author": "Zsilla", "year": "1983", "journal-title": "Eur J Pharmacol"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB88", "doi-asserted-by": "crossref", "first-page": "148", "DOI": "10.1038/281148a0", "article-title": "Specific tricyclic antidepressant binding sites in rat brain", "volume": "281", "author": "Raisman", "year": "1979", "journal-title": "Nature"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB89", "doi-asserted-by": "crossref", "first-page": "2273", "DOI": "10.1016/0024-3205(80)90213-1", "article-title": "Demonstration of specific high affinity binding sites for (3H)imipramine in human brain", "volume": "26", "author": "Rehavi", "year": "1980", "journal-title": "Life Sci"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB90", "doi-asserted-by": "crossref", "first-page": "310", "DOI": "10.1007/BF00501311", "article-title": "(3H)imipramine binding sites in the rat brain. Selective localization on serotonergic neurones", "volume": "317", "author": "Grob", "year": "1981", "journal-title": "Naunyn Schmidebergers Arch Pharmacol"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB91", "first-page": "224", "article-title": "Catechol compounds in rat tissues and brains of different animals", "volume": "180", "author": "Montagy", "year": "1957", "journal-title": "Nature"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB92", "doi-asserted-by": "crossref", "first-page": "10", "DOI": "10.1007/BF02157069", "article-title": "On the distribution in brain monoamines and of enzymes responsible for their formation", "volume": "15", "author": "Bertler", "year": "1959", "journal-title": "Experientia"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB93", "doi-asserted-by": "crossref", "first-page": "97", "DOI": "10.1111/j.1748-1716.1961.tb02118.x", "article-title": "Occurrence and localization of catecholamines in human brain", "volume": "51", "author": "Bertler", "year": "1961", "journal-title": "Acta Physiol Scand"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB94", "doi-asserted-by": "crossref", "first-page": "1647", "DOI": "10.1111/j.1471-4159.1971.tb03738.x", "article-title": "Distribution of tyrosine hydroxylase in human and animal brain", "volume": "18", "author": "McGeer", "year": "1971", "journal-title": "J Neurochem"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB95", "doi-asserted-by": "crossref", "first-page": "536", "DOI": "10.1001/archpsyc.1971.01750120052009", "article-title": "Relation of sex and aging to monoamine oxidase activity of human brain, plasma and platelets", "volume": "24", "author": "Robinson", "year": "1971", "journal-title": "Arch Gen Psychiat."}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB96", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1007/BF01249185", "article-title": "The effect of age on the activity and molecular properties of human brain monoamine oxidase", "volume": "49", "author": "Fowler", "year": "1980", "journal-title": "J Neural Transm"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB97", "doi-asserted-by": "crossref", "first-page": "111", "DOI": "10.1007/BF00692056", "article-title": "Neuronal loss, neurofibrillary tangles and granulovacuolar degeneration in the hippocampus with ageing and dementia. A quantitative study", "volume": "37", "author": "Ball", "year": "1977", "journal-title": "Acta Neuropathol (Berlin)"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB98", "first-page": "289", "article-title": "Some remarks on the wish to die at life's end", "volume": "9", "author": "Leering", "year": "1979", "journal-title": "Akt Gerontol"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB99", "first-page": "277", "article-title": "A field study of depression in old age", "volume": "9", "author": "Stenback", "year": "1979", "journal-title": "Akt Gerontol"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB100", "author": "Martin", "first-page": "813", "year": "1977", "volume-title": "Handbook of Sexology"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB101", "first-page": "297", "article-title": "Inhibition by deprenyl of dopamine uptake in rat striatum: a possible correlation between dopamine uptake and acetylcholine release inhibition", "volume": "31", "author": "H\u00e5rsing", "year": "1979", "journal-title": "Pol J Pharmacol Pharm"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB102", "doi-asserted-by": "crossref", "first-page": "655", "DOI": "10.1111/j.1471-4159.1966.tb09873.x", "article-title": "Regional studies of catecholamines in the rat brain. I. The disposition of 3H-norepinephrine, 3H-dopamine and 3H-DOPA in various regions of the brain", "volume": "13", "author": "Glowinski", "year": "1966", "journal-title": "J Neurochem"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB103", "doi-asserted-by": "crossref", "first-page": "293", "DOI": "10.1111/j.1748-1716.1958.tb01628.x", "article-title": "A fluorimetric method for the determination for DA (3-hydroxytyramine)", "volume": "44", "author": "Carlsson", "year": "1958", "journal-title": "Acta Physiol Scand"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB104", "first-page": "177", "article-title": "Application of steady-state kinetics to the synthesis rate and turnover time of serotonin in the brain of normal and reserpine treated rats. J Pharmac exp", "volume": "153", "author": "Tozer", "year": "1966", "journal-title": "Ther"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB105", "author": "Knoll", "first-page": "135", "year": "1983", "volume-title": "Monoamine Oxidase and Its Selective Inhibitors (Modern Problems of Pharmacopsychiatry"}, {"key": "10.1111/j.1600-0404.1983.tb01517.x-BIB106", "doi-asserted-by": "crossref", "first-page": "249", "DOI": "10.1002/jez.1400970304", "article-title": "Relative effect of androgen upon the mating behavior of males subjected to forebrain injury or castration", "volume": "97", "author": "Beach", "year": "1977", "journal-title": "J exp Zool"}], "container-title": ["Acta Neurologica Scandinavica"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1600-0404.1983.tb01517.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 17]], "date-time": "2019-02-17T09:08:09Z", "timestamp": 1550394489000}, "score": 31.249971, "issued": {"date-parts": [[1983, 7]]}, "references-count": 106, "URL": "http://dx.doi.org/10.1111/j.1600-0404.1983.tb01517.x", "relation": {"cites": []}, "ISSN": ["0001-6314", "1600-0404"], "issn-type": [{"value": "0001-6314", "type": "print"}, {"value": "1600-0404", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T13:47:32Z", "timestamp": 1575294452957}, "reference-count": 22, "publisher": "Elsevier", "isbn-type": [{"value": "9780080263908", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1980]]}, "DOI": "10.1016/b978-0-08-026390-8.50005-4", "type": "book-chapter", "created": {"date-parts": [[2013, 10, 23]], "date-time": "2013-10-23T06:34:00Z", "timestamp": 1382510040000}, "page": "3-13", "source": "Crossref", "is-referenced-by-count": 0, "title": ["OPIATE-A RECEPTORS RELATE TO CHOLINERGIC AND OPIATE-B RECEPTORS TO CATECHOLAMINERGIC NEURONS"], "prefix": "10.1016", "author": [{"given": "J.", "family": "Knoll", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Opiate Receptors and the Neurochemical Correlates of Pain"], "deposited": {"date-parts": [[2018, 10, 11]], "date-time": "2018-10-11T16:52:53Z", "timestamp": 1539276773000}, "score": 31.239748, "issued": {"date-parts": [[1980]]}, "ISBN": ["9780080263908"], "references-count": 22, "URL": "http://dx.doi.org/10.1016/b978-0-08-026390-8.50005-4"}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T22:28:03Z", "timestamp": 1574288883586}, "reference-count": 90, "publisher": "Wiley", "issue": "2", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 6421, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1998, 2]]}, "DOI": "10.1111/j.1600-0773.1998.tb01399.x", "type": "journal-article", "created": {"date-parts": [[2009, 3, 25]], "date-time": "2009-03-25T16:47:35Z", "timestamp": 1237999655000}, "page": "57-66", "source": "Crossref", "is-referenced-by-count": 45, "title": ["(-)Deprenyl (Selegiline), a Catecholaminergic Activity Enhancer (CAE) Substance Acting in the Brain"], "prefix": "10.1111", "volume": "82", "author": [{"given": "Joseph", "family": "Knull", "sequence": "first", "affiliation": []}], "member": "311", "reference": [{"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB1", "doi-asserted-by": "crossref", "first-page": "366", "DOI": "10.1016/0166-2236(89)90074-X", "article-title": "The functional anatomy of basal ganglia disorders", "volume": "12", "author": "Albin", "year": "1989", "journal-title": "Trends Neurosci."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB2", "doi-asserted-by": "crossref", "first-page": "73", "DOI": "10.1111/j.1600-0404.1991.tb05024.x", "article-title": "Selegiline in de novo parkinsonian patients: the French selegiline multicenter trial (FSMP)", "volume": "136", "author": "Allain", "year": "1991", "journal-title": "Acta neurol scand."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB3", "doi-asserted-by": "crossref", "first-page": "19", "DOI": "10.1113/jphysiol.1910.sp001392", "article-title": "Chemical structure and sympathomimetic action of amines", "volume": "41", "author": "Barger", "year": "1910", "journal-title": "J. Physiol. (London)"}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB4", "first-page": "787", "article-title": "Der L-Dioxyphenylalanin (L-DOPA) Effekt bei der Parkinson-Akinesie", "volume": "73", "author": "Birkmayer", "year": "1961", "journal-title": "Wien. Klin. Wochenschrift."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB5", "doi-asserted-by": "crossref", "first-page": "560", "DOI": "10.1007/BF00343235", "article-title": "Der L-Dioxyphenyl-alanin-Effekt beim Parkinson Syndrom des Menschen", "volume": "203", "author": "Birkmayer", "year": "1962", "journal-title": "Arch. Psychiat. Nervenkrh."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB6", "author": "Birkmayer", "first-page": "217", "year": "1980", "volume-title": "Die Parkinson-Krankheit", "DOI": "10.1007/978-3-7091-2253-2", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB7", "doi-asserted-by": "crossref", "first-page": "439", "DOI": "10.1016/S0140-6736(77)91940-7", "article-title": "Implications of combined treatment with \u201cMadopar\u201d and L-Deprenil in Parkinson's disease", "volume": "1", "author": "Birkmayer", "year": "1977", "journal-title": "Lancet"}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB8", "doi-asserted-by": "crossref", "first-page": "113", "DOI": "10.1007/BF01245973", "article-title": "Increased life expectancy resulting from addition of L-deprenyl to Madopar treatment in Parkinson's disease: a longterm study", "volume": "64", "author": "Birkmayer", "year": "1985", "journal-title": "J. Neural Transm."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB9", "doi-asserted-by": "crossref", "first-page": "849", "DOI": "10.1016/S0140-6736(63)92743-0", "article-title": "Hypertensive crisis due to monoamine oxidase inhibitors", "volume": "II", "author": "Blackwell", "year": "1963", "journal-title": "Lancet"}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB10", "doi-asserted-by": "crossref", "first-page": "1219", "DOI": "10.1111/j.1532-5415.1993.tb07306.x", "article-title": "L-Deprenyl in the treatment of mild dementia of the Alzheimer type: results of a 15-month trial", "volume": "41", "author": "Burke", "year": "1993", "journal-title": "J. Amer. Geriatr. Sac."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB11", "doi-asserted-by": "crossref", "first-page": "314", "DOI": "10.1113/jphysiol.1958.sp006104", "article-title": "The action of sympathomimetic amines in animals treated with reserpine", "volume": "144", "author": "Burn", "year": "1958", "journal-title": "J. Physiol. (Lond.)"}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB12", "doi-asserted-by": "crossref", "first-page": "517", "DOI": "10.1016/0024-3205(91)90466-O", "article-title": "(-)Deprcnyl induces activities of both superoxide dismutase and catalase but not of glutathion peroxidase in the striatum of young male rats", "volume": "48", "author": "Carrillo", "year": "1991", "journal-title": "Life Sci."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB13", "doi-asserted-by": "crossref", "first-page": "286", "DOI": "10.1016/0014-4886(92)90008-E", "article-title": "(-)Deprenyl increases activities of superoxide dismutase and catalase in striatum but not in hippocampus: the sex and age-related differences in the optimal dose in the rat", "volume": "116", "author": "Carrillo", "year": "1992", "journal-title": "Exp. Neurol."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB14", "doi-asserted-by": "crossref", "first-page": "209", "DOI": "10.1016/0014-2999(84)90700-3", "article-title": "Pargyline and (-)dcprenyl prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-telrahydropyridine (MPTP) in monkeys", "volume": "106", "author": "Cohen", "year": "1984", "journal-title": "Eur. J. Pharmacol."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB15", "first-page": "124", "article-title": "Sopra alcuni derivati alfatoluici", "volume": "5", "author": "Colombo", "year": "1875", "journal-title": "Gazz. Chim. Ital."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB16", "doi-asserted-by": "crossref", "first-page": "143", "DOI": "10.1046/j.1365-2125.1996.d01-3294.x", "article-title": "Multi-centre trials: Uturns by bandwagons and the patient left by the wayside", "volume": "42", "author": "Dobbs", "year": "1996", "journal-title": "Brit. J. Clin. Pharmacol."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB17", "doi-asserted-by": "crossref", "first-page": "1236", "DOI": "10.1007/BF01485901", "article-title": "Verleilung von Noradrenaline und Dopamine im Gehirn des Menschen und ihre Verhalten bei Erkrankungen des extrapyramidal Systems", "volume": "38", "author": "Ehringer", "year": "1960", "journal-title": "Wien. Klin. Wochenschrift"}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB18", "doi-asserted-by": "crossref", "first-page": "33", "DOI": "10.1007/BF00426954", "article-title": "Deprenyl administration in man; a selective monoamine oxidase B inhibitor without the \u201ccheese effect", "volume": "57", "author": "Elsworth", "year": "1978", "journal-title": "Psychopharmacology"}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB19", "doi-asserted-by": "crossref", "first-page": "119", "DOI": "10.1016/0014-2999(90)90672-S", "article-title": "Protection against DSP-4 induced neurotoxicity by deprenyl is not related to its inhibition of MAO-B", "volume": "184", "author": "Finnegan", "year": "1990", "journal-title": "Eur. J. Pharmacol."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB20", "first-page": "1486", "article-title": "\u03b2-Phenylethylamine in human urine", "volume": "18", "author": "Fischer", "year": "1968", "journal-title": "Arzneimittelf."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB21", "first-page": "359", "article-title": "On the origin and significance of neuromelanin", "volume": "103", "author": "Graham", "year": "1979", "journal-title": "Arch. Pathol. Lab. Med."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB22", "doi-asserted-by": "crossref", "first-page": "1447", "DOI": "10.1016/0006-2952(69)90258-5", "article-title": "Further studies on the mhibition of monoamine oxidase by MB 9302 (clorgyline)", "volume": "18", "author": "Hall", "year": "1969", "journal-title": "Biochem. Pharmacol."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB23", "first-page": "297", "article-title": "Inhibition by (-)deprenyl of dopamine uptake in rat striatum: a possible correlation between dopamine uptake and acetylcholine release inhibition", "volume": "31", "author": "H\u00e1rsing", "year": "1979", "journal-title": "Pol. J. Pharmacol. Pharm."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB24", "doi-asserted-by": "crossref", "first-page": "1285", "DOI": "10.1016/0006-2952(68)90066-X", "article-title": "Some observations upon a new inhibitor of monoamine oxidase in human brain", "volume": "17", "author": "Johnst\u00f3n", "year": "1968", "journal-title": "Biochem. Pharmacol."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB25", "doi-asserted-by": "crossref", "first-page": "643", "DOI": "10.1093/geronj/33.5.643", "article-title": "Age related changes in the mgrostriatum. A behavioral and biochemical analysis", "volume": "33", "author": "Joseph", "year": "1978", "journal-title": "J. Gerantol."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB26", "doi-asserted-by": "crossref", "first-page": "281", "DOI": "10.1016/0024-3205(93)90219-S", "article-title": "Chronic treatment of (-)deprenyl prolongs the life span of male Fischer 344 rats. Further evidence", "volume": "52", "author": "Kitam", "year": "1992", "journal-title": "Life Sci."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB27", "author": "Knoll", "first-page": "131", "year": "1976", "volume-title": "Monoamine oxidase and its inhibition"}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB28", "doi-asserted-by": "crossref", "first-page": "177", "DOI": "10.1007/BF01246955", "article-title": "The possible mechanism of action of (-)deprenyl in Parkinson's disease", "volume": "43", "author": "Knoll", "year": "1978", "journal-title": "J. Neural Transm."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB29", "doi-asserted-by": "crossref", "first-page": "111", "DOI": "10.1016/0166-2236(79)90044-4", "article-title": "(-)Deprenyl the MAO inhibitor without the \u201ccheese effect", "volume": "1", "author": "Knoll", "year": "1979", "journal-title": "Trends Neurosci."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB30", "author": "Knoll", "first-page": "107", "year": "1982", "volume-title": "Strategy in drug research"}, {"issue": "suppl. 95", "key": "10.1111/j.1600-0773.1998.tb01399.x-BIB31", "doi-asserted-by": "crossref", "first-page": "57", "DOI": "10.1111/j.1600-0404.1983.tb01517.x", "article-title": "Deprenyl (selegiline). The history of its development and pharmacological action", "author": "Knoll", "year": "1983", "journal-title": "Acta Neurol. Scand."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB32", "author": "Knoll", "first-page": "7", "year": "1986", "volume-title": "Dopamine, ageing and diseases"}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB33", "first-page": "45", "article-title": "R-(-)Deprenyl (Selegiline. Movergan\u00ae) facilitates the activityof the nigrostriatal dopaminergic neuron", "volume": "25", "author": "Knoll", "year": "1987", "journal-title": "J. Neural Transm."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB34", "doi-asserted-by": "crossref", "first-page": "237", "DOI": "10.1016/0047-6374(88)90128-5", "article-title": "The striatal dopamine dependency of lifespan in male rats. Longevity study with (-)deprenyl", "volume": "46", "author": "Knoll", "year": "1988", "journal-title": "Mech. Ageing & Dev."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB35", "doi-asserted-by": "crossref", "first-page": "83", "DOI": "10.1111/j.1600-0404.1989.tb01787.x", "article-title": "The pharmacology of selegiline /(-)deprenyl", "volume": "126", "author": "Knoll", "year": "1989", "journal-title": "J. Acta Neural. Seand."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB36", "first-page": "425", "article-title": "Nigrostriatal dopaminergic activity, deprenyl treatment. and longevity", "volume": "53", "author": "Knoll", "year": "1990", "journal-title": "Adv. Neurol."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB37", "doi-asserted-by": "crossref", "first-page": "505", "DOI": "10.1002/med.2610120504", "article-title": "Pharmacological basis of the therapeutic effect of (-)deprenyl in age-related neurological diseases", "volume": "12", "author": "Knoll", "year": "1992", "journal-title": "Medicinal Res. Rer."}, {"issue": "suppl. 40", "key": "10.1111/j.1600-0773.1998.tb01399.x-BIB38", "first-page": "69", "article-title": "The pharmacological basis of the beneficial effect of (-)deprenyl (selegiline) in Parkinson's and Alzheimer's diseases", "author": "Knoll", "year": "1993", "journal-title": "J. Nraral. Transm."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB39", "first-page": "65", "article-title": "Memories of my 45 years in research", "volume": "75", "author": "Knoll", "year": "1994", "journal-title": "Pharmacology & Neurology"}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB40", "doi-asserted-by": "crossref", "first-page": "187", "DOI": "10.1016/0753-3322(96)82619-9", "article-title": "Rationale for (-)deprenyl (selegiline) medication in Parkmson'ss disease and in prevention of age-related nigral changes", "volume": "49", "author": "Knoll", "year": "1995", "journal-title": "Biomed. & Tharmucother."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB41", "doi-asserted-by": "crossref", "first-page": "315", "DOI": "10.1016/0753-3322(96)84833-5", "article-title": "(-)Deprenyl (selegiline) in Parkinson's disease: a pharmacologist's comment", "volume": "50", "author": "Knoll", "year": "1996", "journal-title": "Biomed. & Pharmacother."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB42", "first-page": "393", "article-title": "Some puzzling effects of monoamine oxidase inhibitors", "volume": "5", "author": "Knoll", "year": "1972", "journal-title": "Adv. Bioch. Psychopharmacol."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB43", "first-page": "1", "article-title": "Multiple, small dose administration of (-)deprenyl enhances catecholaminergic activity and diminishes scroroninergic activity in the brain and these effects are unrelated to MAO-Binhibition", "volume": "328", "author": "Knoll", "year": "1994", "journal-title": "Arch. int. Pharmacodyn. Th\u00e9r."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB44", "doi-asserted-by": "crossref", "first-page": "611", "DOI": "10.1016/0024-3205(94)00494-D", "article-title": "Enhanced catecholaminergic and serotoninergic activity in rat brain from weaning to sexual maturity. Rationale for prophylactic (-)deprenyl (selegiline) medication", "volume": "56", "author": "Knoll", "year": "1995", "journal-title": "Life Sci."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB45", "first-page": "154", "article-title": "Z. Ecseri, K. Kelemen, J. Nievel & B. Knoll: Phenylisopropvlmethyl propinylamine (E-250) a new psychic energizer", "volume": "155", "author": "Knoll", "year": "1965", "journal-title": "Arch, int. Pharmacodyn. Tit\u00e9r."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB46", "first-page": "109", "article-title": "Phenylisopropylmethylpropinylamine (E-250), a monoamine oxidase inhibitor antagonizing the effects of tyramine", "volume": "18", "author": "Knoll", "year": "1968", "journal-title": "Arzneimittelf."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB47", "doi-asserted-by": "crossref", "first-page": "135", "DOI": "10.1159/000407510", "article-title": "Long-lasting, true aphrodisiac effect of (-)deprenyl in sexually sluggish old male rats", "volume": "19", "author": "Knoll", "year": "1983", "journal-title": "Mod. Probl. Pharmacopsychiat."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB48", "doi-asserted-by": "crossref", "first-page": "525", "DOI": "10.1016/0024-3205(89)90103-3", "article-title": "Striatal dopamine, sexual activity and lifespan. Longevity of rats treated with (-)deprenyl", "volume": "45", "author": "Knoll", "year": "1989", "journal-title": "Life Sci."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB49", "first-page": "5", "article-title": "The pharmacology of l-phenyl-2-propylaminopentane (PPAP), a deprenylderived new spectrum psychostimulant", "volume": "316", "author": "Knoll", "year": "1992", "journal-title": "Arch. int. Pharmacodyn. Tit\u00e9r."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB50", "doi-asserted-by": "crossref", "first-page": "157", "DOI": "10.1016/0047-6374(92)90061-H", "article-title": "(-)Deprenyl and (-)parafluorodeprenyl-treatment prevents age-related pigment changes in the substantia nigra. A TV-image analysis of neuromelanin", "volume": "63", "author": "Knoll", "year": "1992", "journal-title": "Mech. Ageing & Dev."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB51", "doi-asserted-by": "crossref", "first-page": "1047", "DOI": "10.1016/0024-3205(94)00415-3", "article-title": "Sexually low performing male rats dies earlier than their high performing peers and (-)deprenyl treatment eliminates this difference", "volume": "54", "author": "Knoll", "year": "1994", "journal-title": "Life Sci."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB52", "doi-asserted-by": "crossref", "first-page": "817", "DOI": "10.1016/0024-3205(96)00014-8", "article-title": "(-)-Deprenyl and (-)l-phenyl-2-propylaminopentane. [(-)PPAP], act primarily as potent stimulants of action potential - transmitter release coupling in the catecholaminergic neurons", "volume": "58", "author": "Knoll", "year": "1996", "journal-title": "Life Sci."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB53", "doi-asserted-by": "crossref", "first-page": "2101", "DOI": "10.1016/0024-3205(96)00204-4", "article-title": "Phenylethylamine and tyramine are mixed-acting sympathomimetic amines in the brain", "volume": "58", "author": "Knoll", "year": "1996", "journal-title": "Life Sci."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB54", "doi-asserted-by": "crossref", "first-page": "1883", "DOI": "10.1161/01.STR.26.10.1883", "article-title": "L-deprenyl reduces brain damage in rats exposed to transient hypoxia-ischemia", "volume": "26", "author": "Knollema", "year": "1995", "journal-title": "Stroke"}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB55", "doi-asserted-by": "crossref", "first-page": "1602", "DOI": "10.1136/bmj.311.7020.1602", "article-title": "Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease", "volume": "311", "author": "Lees", "year": "1995", "journal-title": "Br. Med. J."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB56", "doi-asserted-by": "crossref", "first-page": "100", "DOI": "10.1159/000116655", "article-title": "Effects of a MAO-B inhibitor in the treatment of Alzheimer disease", "volume": "31", "author": "Mangoni", "year": "1991", "journal-title": "Eur. Neurol."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB57", "doi-asserted-by": "crossref", "first-page": "877", "DOI": "10.1016/0024-3205(80)90350-1", "article-title": "A selective monoamine oxidase-B inhibitor in endogenous depression", "volume": "26", "author": "Mann", "year": "1980", "journal-title": "Life Set."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB58", "author": "Martin", "first-page": "813", "year": "1977", "volume-title": "Handbook of sexology"}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB59", "doi-asserted-by": "crossref", "first-page": "256", "DOI": "10.1055/s-2007-1017117", "article-title": "Brief information on an early phase-II study with (-)deprenyl in demented patients", "volume": "20", "author": "Martini", "year": "1987", "journal-title": "Pharmacopsychiatry"}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB60", "doi-asserted-by": "crossref", "first-page": "415", "DOI": "10.1016/0024-3205(90)90299-7", "article-title": "Maintenance on L-(-)deprenyl prolongs life in aged male rats", "volume": "47", "author": "Milgram", "year": "1990", "journal-title": "Life Sci."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB61", "doi-asserted-by": "crossref", "first-page": "950", "DOI": "10.1016/0959-4388(93)90167-W", "article-title": "Basal ganglia intrinsic circuits and their role in behavior", "volume": "3", "author": "Mink", "year": "1993", "journal-title": "Curr. Opinion in Neurobiol."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB62", "doi-asserted-by": "crossref", "first-page": "339", "DOI": "10.1212/WNL.42.2.339", "article-title": "Selegiline as initial treatment in de novo parkinsonian patients", "volume": "42", "author": "Myttyla", "year": "1992", "journal-title": "Neurology"}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB63", "first-page": "319", "article-title": "Formation of P-phenylethylamine in mammalian tissue and its effect on motor activity", "volume": "143", "author": "Nakajima", "year": "1964", "journal-title": "J. Pharm."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB64", "doi-asserted-by": "crossref", "first-page": "702", "DOI": "10.1136/bmj.312.7032.702b", "article-title": "Effect of adding selegiline to levodopa in early, mild Parkinson's disease. Patients taking selegiline may have received more levodopa than necessary", "volume": "312", "author": "Olanow", "year": "1996", "journal-title": "Br. Med. J."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB65", "doi-asserted-by": "crossref", "first-page": "1364", "DOI": "10.1056/NEJM198911163212004", "article-title": "Effect of (-)deprenyl on the progression disability in early Parkinson's disease", "volume": "321", "author": "Parkinson Study Group", "year": "1989", "journal-title": "New Engl. J. Med."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB66", "first-page": "176", "article-title": "Effect to tocopherol and (-)deprenyl on the progression of disability in early Parkinson's disease. New Engl. J", "volume": "328", "author": "Parkinson Study Group", "year": "1993", "journal-title": "Med."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB67", "doi-asserted-by": "crossref", "first-page": "37", "DOI": "10.1002/ana.410390107", "article-title": "Impact of deprenyl and tocopherol treatment of Parkinson's disease in DATATOP patients requiring levodopa", "volume": "39", "author": "Parkinson Study Group", "year": "1996", "journal-title": "Ann. Neurol."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB68", "doi-asserted-by": "crossref", "first-page": "147", "DOI": "10.1097/00002826-199004000-00004", "article-title": "Neuropsychological effects of L-deprenyl in Alzheimer's type dementia", "volume": "13", "author": "Piecinin", "year": "1990", "journal-title": "Clin. Neuropharmacol."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB69", "doi-asserted-by": "crossref", "first-page": "2051", "DOI": "10.1001/jama.1935.02760510023006", "article-title": "The use of benzedrine for the treatment of narcolepsy", "volume": "105", "author": "Prinzmetal", "year": "1935", "journal-title": "JAMA."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB70", "doi-asserted-by": "crossref", "first-page": "859", "DOI": "10.1212/WNL.41.6.859", "article-title": "Selegiline (deprenyl) treatment and death of nigral neurons in Parkinson's disease", "volume": "41", "author": "Rinne", "year": "1991", "journal-title": "Neurology"}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB71", "author": "Rogers", "first-page": "645", "year": "1985", "volume-title": "Handbook on the biology of aging"}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB72", "doi-asserted-by": "crossref", "first-page": "1037", "DOI": "10.1016/S0024-3205(97)00611-5", "article-title": "Treatment with L-deprenyl prolongs life in elderly dogs", "volume": "61", "author": "Ruehl", "year": "1997", "journal-title": "Life Sei."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB73", "doi-asserted-by": "crossref", "first-page": "1216", "DOI": "10.1056/NEJM199704243361704", "article-title": "A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease", "volume": "336", "author": "Sano", "year": "1997", "journal-title": "New Engl. J. Med."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB74", "doi-asserted-by": "crossref", "first-page": "466", "DOI": "10.1007/s004010050453", "article-title": "Monoamine oxidase B inhibitor selegiline protects young and aged rat peripheral sympathetic neurons against 6-hydroxydopaminc-induced neurotoxicity", "volume": "91", "author": "Salonen", "year": "1996", "journal-title": "Acta Neuropathol."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB75", "doi-asserted-by": "crossref", "first-page": "147", "DOI": "10.1016/0006-8993(80)91015-X", "article-title": "Reduced dopaminergic binding during aging in the rodent striatum", "volume": "192", "author": "Severson", "year": "1980", "journal-title": "Brain Res."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB76", "author": "Standaert", "first-page": "503", "year": "1996", "volume-title": "Goodman & Oilman's The pharmaeologieal basis of therapeutics"}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB77", "doi-asserted-by": "crossref", "first-page": "427", "DOI": "10.1001/archpsyc.1987.01800170041007", "article-title": "L-(-)Dcprenyl in Alzheimer's disease", "volume": "44", "author": "Tariot", "year": "1987", "journal-title": "Arch. Gen. Psychiatry."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB78", "doi-asserted-by": "crossref", "first-page": "666", "DOI": "10.1002/jnr.490300410", "article-title": "Rescue of dying neurons: a new action for deprenyl in MPTP parkinsonism", "volume": "30", "author": "Tatton", "year": "1991", "journal-title": "J. Neurosci. Res."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB79", "doi-asserted-by": "crossref", "first-page": "1572", "DOI": "10.1046/j.1471-4159.1994.63041572.x", "article-title": "(-)-Deprenyl reduces apoptosis by inducing new protein synthesis", "volume": "63", "author": "Tatton", "year": "1994", "journal-title": "J. Neurochem."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB80", "doi-asserted-by": "crossref", "first-page": "519", "DOI": "10.1126/science.2502843", "article-title": "The effect of (-)deprenyl (selegiline) on the natural history of Parkinson's disease", "volume": "245", "author": "Tetrud", "year": "1989", "journal-title": "Science"}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB81", "doi-asserted-by": "crossref", "first-page": "185", "DOI": "10.1016/0006-8993(80)91018-5", "article-title": "Evidence for loss of brain 3H-spiroperidol and 3H-ADTN binding sites in rabbit brain with aging", "volume": "192", "author": "Thal", "year": "1980", "journal-title": "Brain Res."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB82", "author": "Tringer", "first-page": "111", "year": "1971", "volume-title": "V. Conferentia Hungarica pro Therapia et Investigatione in Pharmacologia"}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB83", "doi-asserted-by": "crossref", "first-page": "215", "DOI": "10.1016/0047-6374(92)90067-N", "article-title": "A procedure for measuring neuromelanin in neurocytes by a TV-image analyser", "volume": "63", "author": "T\u00f3th", "year": "1992", "journal-title": "Mech. Ageing & Dev."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB84", "author": "Varga", "first-page": "197", "year": "1965", "volume-title": "III. Conferentia Hungarica pro Therapia el Investigatione in Phctrmacologia"}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB85", "first-page": "289", "article-title": "Clinical trial of a new type of promptly acting psychoenergetic agent (phenyl-isopropylmethyl-propinylamine HCl, E-250)", "volume": "23", "author": "Varga", "year": "1967", "journal-title": "Acta Med. Acad. Sci. Hung."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB86", "doi-asserted-by": "crossref", "first-page": "113", "DOI": "10.1016/0304-3940(93)90496-8", "article-title": "Protective effect of deprenyl against l-methyl-4-phenylpyridinium neurotoxicity in rat striatum", "volume": "152", "author": "Vizuete", "year": "1993", "journal-title": "Neurosci. Lett."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB87", "doi-asserted-by": "crossref", "first-page": "241", "DOI": "10.1016/0014-2999(93)90181-G", "article-title": "Apparent antioxidant effect of l-deprenyl on hydroxyl radical formation and nigral injury elicited by MPP+in vivo", "volume": "243", "author": "Wu", "year": "1993", "journal-title": "Eur. J. Pharmacol."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB88", "author": "Yasar", "first-page": "215", "year": "1993", "volume-title": "Inhibitors of Monoamine Oxidase B", "DOI": "10.1007/978-3-0348-6348-3_11", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB89", "doi-asserted-by": "crossref", "first-page": "233", "DOI": "10.1006/exnr.1994.1061", "article-title": "Deprenyl alters the time course of death of axotomized facial motoneurons and the hypertrophy of neighboring astrocytes in immature rats", "volume": "126", "author": "Yu", "year": "1994", "journal-title": "Exp. Neurol."}, {"key": "10.1111/j.1600-0773.1998.tb01399.x-BIB90", "doi-asserted-by": "crossref", "first-page": "464", "DOI": "10.1002/jnr.490400416", "article-title": "CNTF or (-)-deprenyl in immature rats: survival of axotomized facial motoneurons and weight loss", "volume": "40", "author": "Zhang", "year": "1995", "journal-title": "J. Neurosci. Res."}], "container-title": ["Pharmacology & Toxicology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1600-0773.1998.tb01399.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 18]], "date-time": "2019-02-18T23:04:10Z", "timestamp": 1550531050000}, "score": 30.806282, "issued": {"date-parts": [[1998, 2]]}, "references-count": 90, "journal-issue": {"published-print": {"date-parts": [[1998, 2]]}, "issue": "2"}, "URL": "http://dx.doi.org/10.1111/j.1600-0773.1998.tb01399.x", "relation": {"cites": []}, "ISSN": ["0901-9928", "1600-0773"], "issn-type": [{"value": "0901-9928", "type": "print"}, {"value": "1600-0773", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T08:39:51Z", "timestamp": 1574152791557}, "reference-count": 58, "publisher": "Elsevier BV", "issue": "1-3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1988, 1, 1]], "date-time": "1988-01-01T00:00:00Z", "timestamp": 567993600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Mechanisms of Ageing and Development"], "published-print": {"date-parts": [[1988, 1]]}, "DOI": "10.1016/0047-6374(88)90128-5", "type": "journal-article", "created": {"date-parts": [[2003, 2, 12]], "date-time": "2003-02-12T07:54:37Z", "timestamp": 1045036477000}, "page": "237-262", "source": "Crossref", "is-referenced-by-count": 173, "title": ["The striatal dopamine dependency of life span in male rats. Longevity study with (\u2212)deprenyl"], "prefix": "10.1016", "volume": "46", "author": [{"given": "Joseph", "family": "Knoll", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Mechanisms of Ageing and Development"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:0047637488901285?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:0047637488901285?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 3, 28]], "date-time": "2019-03-28T05:26:32Z", "timestamp": 1553750792000}, "score": 30.237427, "issued": {"date-parts": [[1988, 1]]}, "references-count": 58, "journal-issue": {"published-print": {"date-parts": [[1988, 1]]}, "issue": "1-3"}, "alternative-id": ["0047637488901285"], "URL": "http://dx.doi.org/10.1016/0047-6374(88)90128-5", "ISSN": ["0047-6374"], "issn-type": [{"value": "0047-6374", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T14:42:25Z", "timestamp": 1575297745884}, "reference-count": 0, "publisher": "Elsevier", "isbn-type": [{"value": "9780080237688", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1978]]}, "DOI": "10.1016/b978-0-08-023768-8.51552-8", "type": "book-chapter", "created": {"date-parts": [[2013, 10, 23]], "date-time": "2013-10-23T10:22:34Z", "timestamp": 1382523754000}, "page": "597", "source": "Crossref", "is-referenced-by-count": 0, "title": ["INHIBITION OF DOPAMINE UPTAKE IN THE RAT STRIATUM AS A POSSIBLE MECHANISM OF ACTION OF (-)DEPRENYL IN PARKINSON'S DISEASE"], "prefix": "10.1016", "author": [{"suffix": "Jr.", "given": "L.G.H.", "family": "\u00c1rsing", "sequence": "first", "affiliation": []}, {"given": "J.", "family": "Knoll", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Abstracts"], "deposited": {"date-parts": [[2018, 10, 11]], "date-time": "2018-10-11T15:21:03Z", "timestamp": 1539271263000}, "score": 30.067268, "issued": {"date-parts": [[1978]]}, "ISBN": ["9780080237688"], "references-count": 0, "URL": "http://dx.doi.org/10.1016/b978-0-08-023768-8.51552-8"}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T08:05:13Z", "timestamp": 1574150713528}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1990, 7, 1]], "date-time": "1990-07-01T00:00:00Z", "timestamp": 646790400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Journal of Pharmacology"], "published-print": {"date-parts": [[1990, 7]]}, "DOI": "10.1016/0014-2999(90)93343-o", "type": "journal-article", "created": {"date-parts": [[2003, 1, 30]], "date-time": "2003-01-30T15:52:50Z", "timestamp": 1043941970000}, "page": "454-455", "source": "Crossref", "is-referenced-by-count": 0, "title": ["1-phenyl-2-propyl-aminopentane.HCl (MK-306): a deprenyl-derived new spectrum psychostimulant"], "prefix": "10.1016", "volume": "183", "author": [{"given": "B.", "family": "Knoll", "sequence": "first", "affiliation": []}, {"given": "S.", "family": "Yasar", "sequence": "additional", "affiliation": []}, {"given": "I.", "family": "Farag\u00f3", "sequence": "additional", "affiliation": []}, {"given": "I.", "family": "Kov\u00e1cs", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Knoll", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Journal of Pharmacology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:001429999093343O?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:001429999093343O?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 3, 30]], "date-time": "2019-03-30T06:29:04Z", "timestamp": 1553927344000}, "score": 29.060146, "issued": {"date-parts": [[1990, 7]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1990, 7]]}, "issue": "2"}, "alternative-id": ["001429999093343O"], "URL": "http://dx.doi.org/10.1016/0014-2999(90)93343-o", "ISSN": ["0014-2999"], "issn-type": [{"value": "0014-2999", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T10:15:31Z", "timestamp": 1575108931015}, "reference-count": 39, "publisher": "Springer Science and Business Media LLC", "issue": "3-4", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[1978, 9, 1]], "date-time": "1978-09-01T00:00:00Z", "timestamp": 273456000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J. Neural Transmission"], "published-print": {"date-parts": [[1978, 9]]}, "DOI": "10.1007/bf01246955", "type": "journal-article", "created": {"date-parts": [[2005, 2, 27]], "date-time": "2005-02-27T01:54:35Z", "timestamp": 1109469275000}, "page": "177-198", "source": "Crossref", "is-referenced-by-count": 168, "title": ["The possible mechanisms of action of (-)deprenyl in Parkinson's disease"], "prefix": "10.1007", "volume": "43", "author": [{"given": "J.", "family": "Knoll", "sequence": "first", "affiliation": []}], "member": "297", "reference": [{"key": "CR1", "doi-asserted-by": "crossref", "first-page": "515", "DOI": "10.1016/0028-3908(76)90101-5", "volume": "15", "author": "G. Bartholini", "year": "1976", "unstructured": "Bartholini, G., Stadler, H., Gadea-Ciria, M., Lloyd, K. G. The use of the push-pull cannula to estimate the dynamics of acetylcholine and catecholamines within various brain areas. Neuropharm.15, 515 (1976).", "journal-title": "Neuropharm."}, {"key": "CR2", "doi-asserted-by": "crossref", "first-page": "560", "DOI": "10.1007/BF00343235", "volume": "203", "author": "W. Birkmayer", "year": "1962", "unstructured": "Birkmayer, W., Hornykiewicz, O. Der Dioxyphenylalanin-(L-Dopa-)Effekt beim Parkinson-Syndrom des Menschen. Arch. Psych.203, 560 (1962).", "journal-title": "Arch. Psych."}, {"key": "CR3", "doi-asserted-by": "crossref", "first-page": "303", "DOI": "10.1007/BF01253131", "volume": "36", "author": "W. Birkmayer", "year": "1975", "unstructured": "Birkmayer, W., Riederer, P., Youdim, M. B. H., Linauer, W. The potentation of the anti-akinetic effect after L-dopa treatment by an inhibitor of MAO-B, Deprenyl. J. Neural Transm.36, 303 (1975).", "journal-title": "Deprenyl. J. Neural Transm."}, {"key": "CR4", "doi-asserted-by": "crossref", "first-page": "439", "DOI": "10.1016/S0140-6736(77)91940-7", "volume": "1", "author": "W. Birkmayer", "year": "1977", "unstructured": "Birkmayer, W., Riederer, P., Ambrozi, L., Youdim, M. B. H. Implications of combined treatment with ?Madopar? and l-deprenyl in Parkinson's disease. The Lancet1, 439 (1977).", "journal-title": "The Lancet"}, {"key": "CR5", "doi-asserted-by": "crossref", "first-page": "181", "DOI": "10.1016/0014-2999(75)90238-1", "volume": "34", "author": "C. Braestrup", "year": "1975", "unstructured": "Braestrup, C., Andersen, H., Randrup, A. The monoamine oxidase B inhibitor, deprenyl potentiates phenylethylamine behavior in rats without inhibition of catecholamine metabolite formation. Eur. J. Pharm.34, 181 (1975).", "journal-title": "Eur. J. Pharm."}, {"key": "CR6", "author": "A. Carlsson", "first-page": "49 to 66", "year": "1975", "unstructured": "Carlsson, A. Receptor-mediated control of dopamine metabolism. In: Pre-and Postsynaptic Receptors (Usdin, E., Bunney, W. E., jr., eds.), pp. 49 to 66. New York: Marcel Dekker. 1975.", "volume-title": "Pre-and Postsynaptic Receptors"}, {"key": "CR7", "doi-asserted-by": "crossref", "first-page": "494", "DOI": "10.1176/ajp.112.7.494", "volume": "112", "author": "G. E. Crane", "year": "1956", "unstructured": "Crane, G. E. Psychiatric side effects of iproniazid. Am. J. Psychiatr.112, 494 (1956).", "journal-title": "Am. J. Psychiatr."}, {"key": "CR8", "doi-asserted-by": "crossref", "first-page": "1236", "DOI": "10.1007/BF01485901", "volume": "38", "author": "H. Ehringer", "year": "1960", "unstructured": "Ehringer, H., Hornykiewicz, O. Verteilung von Noradrenalin und Dopamin (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des Extrapyramidalen Systems. Klin. Wschr.38, 1236 (1960).", "journal-title": "Klin. Wschr."}, {"key": "CR9", "unstructured": "Elsworth, J. D., Glover, V., Reynolds, G. P., Sandler, M., Lees, A. J., Phuapradit, P., Shaw, K. M., Stern, G. M., Kumar, P.: Deprenyl administration in man: a selective monoamine oxidase B inhibitor without the ?cheese effect?. Neuropharmacol. (in press).", "DOI": "10.1007/BF00426954", "doi-asserted-by": "crossref"}, {"key": "CR10", "doi-asserted-by": "crossref", "first-page": "129", "DOI": "10.1126/science.116.3006.129", "volume": "116", "author": "H. H. Fox", "year": "1952", "unstructured": "Fox, H. H. The chemical approach to the control of tuberculosis. Science116, 129 (1952).", "journal-title": "Science"}, {"key": "CR11", "first-page": "1373", "volume": "54", "author": "F. Gerstenbrand", "year": "1965", "unstructured": "Gerstenbrand, F., Prosenz, P. \u00dcber die Behandlung des Parkinsonsyndroms mit Monoaminooxydasehemmern allein und in Kombination mit L-Dopa. Praxis54, 1373 (1965).", "journal-title": "Praxis"}, {"key": "CR12", "doi-asserted-by": "crossref", "first-page": "80", "DOI": "10.1038/265080a0", "volume": "265", "author": "V. Glover", "year": "1977", "unstructured": "Glover, V., Sandler, M., Owen, F., Riley, G. J. Dopamine is a monoamine oxidase B substrate in man. Nature265, 80 (1977).", "journal-title": "Nature"}, {"key": "CR13", "year": "1975", "unstructured": "Goodman, L. S., Gilman, A. (eds.): The Pharmacological Basis of Therapeutics. New York: Macmillan. 1975.", "volume-title": "The Pharmacological Basis of Therapeutics"}, {"key": "CR14", "doi-asserted-by": "crossref", "first-page": "227", "DOI": "10.1016/0006-8993(75)90978-6", "volume": "84", "author": "P. Guyenet", "year": "1975", "unstructured": "Guyenet, P., Agid, Y., Javoy, F., Beaujouan, J. C., Rossier, J., Glowinski, J. Effects of dopaminergic receptor agonist and antagonists on the activity of the neostriatal cholinergic system. Brain Res.84, 227 (1975).", "journal-title": "Brain Res."}, {"key": "CR15", "doi-asserted-by": "crossref", "first-page": "388", "DOI": "10.1136/bmj.3.5719.388", "volume": "3", "author": "K. R. Hunter", "year": "1970", "unstructured": "Hunter, K. R., Boakes, A. J., Laurence, D. R., Stern, G. M. Monoamine oxidase inhibitors and l-dopa. Br. Med. J.3, 388 (1970).", "journal-title": "Br. Med. J."}, {"key": "CR16", "doi-asserted-by": "crossref", "first-page": "1285", "DOI": "10.1016/0006-2952(68)90066-X", "volume": "17", "author": "J. P. Johnston", "year": "1968", "unstructured": "Johnston, J. P. Some observations upon a new inhibitor of monoamine oxidase in brain tissue. Biochem. Pharmacol.17, 1285 (1968).", "journal-title": "Biochem. Pharmacol."}, {"key": "CR17", "first-page": "72", "volume": "19", "author": "N. S. Kline", "year": "1958", "unstructured": "Kline, N. S. Clinical experience with iproniazid (marsilid). J. Clin. Exp. Psychopathol.19, 72 (1958).", "journal-title": "J. Clin. Exp. Psychopathol."}, {"key": "CR18", "first-page": "231", "volume": "15", "author": "J. Knoll", "year": "1964", "unstructured": "Knoll, J., Ecsery, Z., Nievel, J., Knoll, B. Phenylisopropyl-methylpropinylamin HCl. E-250 egy \u00faj hat\u00e1sspektrum\u00fa pszichoenergetikum. MTA V. Oszt. K\u00f6zl.15, 231 (1964).", "journal-title": "MTA V. Oszt. K\u00f6zl."}, {"key": "CR19", "first-page": "154", "volume": "155", "author": "J. Knoll", "year": "1965", "unstructured": "Knoll, J., Ecsery, Z., Kelemen, K., Nievel, J., Knoll, B. Phenylisopropyl-methylpropinylamine (E-250), a new spectrum psychic energizer. Arch. Int. Pharmacodyn.155, 154 (1965).", "journal-title": "Arch. Int. Pharmacodyn."}, {"key": "CR20", "first-page": "33", "volume": "18", "author": "J. Knoll", "year": "1967", "unstructured": "Knoll, J., Vizi, E. S., Somogyi, G. A phenyl-isopropyl-methyl-propinylamine (E-250) tyraminantagonista hat\u00e1sa. MTA V. Oszt. K\u00f6zl.18, 33 (1967).", "journal-title": "MTA V. Oszt. K\u00f6zl."}, {"key": "CR21", "first-page": "109", "volume": "18", "author": "J. Knoll", "year": "1968", "unstructured": "Knoll, J., Vizi, E. S., Somogyi, G. Phenylisopropylmethylpropinylamine (E-250), a monoamine oxidase inhibitor antagonizing the effects of tyramine. Arzneim.-Forsch.18, 109 (1968).", "journal-title": "Arzneim.-Forsch."}, {"key": "CR22", "author": "J. Knoll", "first-page": "393 to 408", "year": "1972", "unstructured": "Knoll, J., Magyar, K. Some puzzling effects of monoamine oxidase inhibitors. In: Monoamine Oxidase-New Vistas. Advances in Biochemical Psychopharmacology, Vol. 5 (Costa, E., Sandler, M., eds.), pp. 393 to 408. New York: Raven Press. 1972.", "volume-title": "Monoamine Oxidase-New Vistas. Advances in Biochemical Psychopharmacology, Vol. 5"}, {"key": "CR23", "author": "J. Knoll", "first-page": "167", "year": "1972", "unstructured": "Knoll, J., Vizi, E. S., Magyar, K. Pharmacological studies on some central effects of amphetamines. In: Recent developments of neurobiology in Hungary. III, Results in neuroanatomy, neurophysiology, neuropathophysiology and neuropharmacology (Liss\u00e1k, K., ed.), pp. 167?217. Budapest: Publishing House of the Hungarian Academy ofSciences. 1972 b.", "volume-title": "Recent developments of neurobiology in Hungary. III, Results in neuroanatomy, neurophysiology, neuropathophysiology and neuropharmacology"}, {"key": "CR24", "author": "J. Knoll", "first-page": "135", "year": "1976", "unstructured": "Knoll, J. Analysis of the pharmacological effects of selective monoamine oxidase inhibitors. In: Monoamine Oxidase and its Inhibition (Ciba Foundation Symposium 39, new series), pp. 135?161. Amsterdam-Oxford-New York: Elsevier-Excerpta Medica-North Holland. 1976 a.", "volume-title": "Monoamine Oxidase and its Inhibition (Ciba Foundation Symposium 39, new series)"}, {"key": "CR25", "author": "J. Knoll", "first-page": "109", "year": "1976", "unstructured": "Knoll, J. Heterogeneity of monoamine oxidase: phenylethylamine oxidase and serotonin oxidase. In: Neuron Concept Today (Szent\u00e1gothai, J., H\u00e1mori, J., Vizi, E. S., eds.), pp. 109?117. Budapest: Akad\u00e9miai Kiad\u00f3. 1976 b.", "volume-title": "Neuron Concept Today"}, {"key": "CR26", "unstructured": "Knoll, J.: On the dual nature of monoamine oxidase. In: Horizons in Biochemistry and Biophysics, Vol. 5 (in press)."}, {"key": "CR27", "unstructured": "Knoll, J., Ecsery, Z., Magyar, K., S\u00e1tory, \u00c9.: Novel (-)deprenyl derived selective inhibitors of B-type MAO. The relation of structure to their actions. Biochem. Pharm. (in press)."}, {"key": "CR28", "doi-asserted-by": "crossref", "first-page": "791", "DOI": "10.1016/S0140-6736(77)90725-5", "volume": "1", "author": "A. J. Lees", "year": "1977", "unstructured": "Lees, A. J., Shaw, K. M., Kohout, L. J., Stern, G. M., Elsworth, J. D., Sandler, M., Youdim, M. B. H. Deprenyl in Parkinson's disease. The Lancet1, 791 (1977).", "journal-title": "The Lancet"}, {"key": "CR29", "first-page": "377", "volume": "32", "author": "K. Magyar", "year": "1967", "unstructured": "Magyar, K., Vizi, E. S., Ecsery, Z., Knoll, J. Comparative pharmacological analysis of the optical isomers of phenyl-isopropyl-methyl-propinyl-amine (E-250). Acta Physiol. Hung.32, 377 (1967).", "journal-title": "Acta Physiol. Hung."}, {"key": "CR30", "author": "K. Magyar", "first-page": "107", "year": "1973", "unstructured": "Magyar, K., S\u00e1tory, \u00c9., Knoll, J. Selective inhibition of monoamine oxidase by deprenyl. In: First Congress of the Hungarian Pharmacological Society, Vol. L. Symposium on Pharmacological Agents and Biogenic Amines in the Nervous System (Knoll, J., gen. ed.,Magyar, K., ed.), pp. 107?122. Budapest: Akad\u00e9miai Kiad\u00f3. 1973.", "volume-title": "First Congress of the Hungarian Pharmacological Society, Vol. L"}, {"key": "CR31", "doi-asserted-by": "crossref", "first-page": "399", "DOI": "10.1113/jphysiol.1967.sp008175", "volume": "189", "author": "H. McLennan", "year": "1967", "unstructured": "McLennan, H., York, D. H. The action of dopamine on neurons of the caudate nucleus. J. Physiol.189, 399 (1967).", "journal-title": "J. Physiol."}, {"key": "CR32", "doi-asserted-by": "crossref", "first-page": "819", "DOI": "10.1113/jphysiol.1971.sp009500", "volume": "215", "author": "W. D. M. Paton", "year": "1971", "unstructured": "Paton, W. D. M., Vizi, E. S., Zar, M. A. The mechanism of acetylcholine release from parasympathetic nerves. J. Physiol.215, 819 (1971).", "journal-title": "J. Physiol."}, {"key": "CR33", "first-page": "51", "volume": "31", "author": "N. Popov", "year": "1973", "unstructured": "Popov, N., Pohle, W., L\u00f6ssner, B., Schulzeck, S., Schmidt, S., Ott, T., Matthies, H. Regional distribution of RNA and protein radioactivity in the rat brain after intraventricular application of labelled precursors. Acta Biol. med. ger.31, 51 (1973).", "journal-title": "Acta Biol. med. ger."}, {"key": "CR34", "author": "R. F. Squires", "first-page": "355", "year": "1972", "unstructured": "Squires, R. F. Multiple forms of monoamine oxidase in intact mitochondria as characterized by selective inhibitors and thermal stability: A comparison of eight mammalian species. In: Monoamine Oxidase-New Vistas. Advances in Biochemical Psychopharmacology, Vol. 5 (Costa, E., Sandler, M., eds.), pp. 355?377. New York: Raven Press. 1972.", "volume-title": "Monoamine Oxidase-New Vistas. Advances in Biochemical Psychopharmacology, Vol. 5"}, {"key": "CR35", "first-page": "289", "volume": "23", "author": "A. Varga", "year": "1967", "unstructured": "Varga, A., Tringer, L. Clinical trial of a new type of promptly acting psychoenergetic agent (phenyl-isopropyl-methyl-propinylamine\u00b7HCl (E-250). Acta Med. Acad. Sci. Hung.23, 289 (1967).", "journal-title": "Acta Med. Acad. Sci. Hung."}, {"key": "CR36", "doi-asserted-by": "crossref", "first-page": "95", "DOI": "10.1113/jphysiol.1972.sp009975", "volume": "226", "author": "E. S. Vizi", "year": "1972", "unstructured": "Vizi, E. S. Stimulation by inhibition of Na+-K+-Mg2+-activated ATPase, of acetylcholine release in cortical slices from rat brain. J. Physiol.226, 95 (1972).", "journal-title": "J. Physiol."}, {"key": "CR37", "doi-asserted-by": "crossref", "first-page": "953", "DOI": "10.1016/0306-4522(77)90118-X", "volume": "2", "author": "E. S. Vizi", "year": "1977", "unstructured": "Vizi, E. S., H\u00e1rsing, L. G., Knoll, J. Presynaptic inhibition leading to disinhibition of acetylcholine release from interneurons of the caudate nucleus: effect of dopamine, beta-endorphin and D-Ala2-Pro5-enkephalinamide. Neuroscience2, 953 (1977).", "journal-title": "Neuroscience"}, {"key": "CR38", "first-page": "365", "volume": "187", "author": "H. Y. Yang", "year": "1973", "unstructured": "Yang, H. Y., Neff, N. H. Beta-phenylethylamine. A specific substrate for type B monoamine oxidase of brain. J. Pharmacol. Exp. Ther.187, 365 (1973).", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "CR39", "doi-asserted-by": "crossref", "first-page": "459", "DOI": "10.3181/00379727-81-19910", "volume": "81", "author": "A. A. Zeller", "year": "1952", "unstructured": "Zeller, A. A., Barsky, J. In vivo inhibition of liver and brain monoamine oxidase by 1-isonicotinyl-2-isopropylhydrazine. Proc. Soc. Exp. Biol. Med.81, 459 (1952).", "journal-title": "Proc. Soc. Exp. Biol. Med."}], "container-title": ["Journal of Neural Transmission"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/BF01246955.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/BF01246955/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/BF01246955", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 30]], "date-time": "2019-04-30T17:51:18Z", "timestamp": 1556646678000}, "score": 28.57974, "issued": {"date-parts": [[1978, 9]]}, "references-count": 39, "journal-issue": {"published-print": {"date-parts": [[1978, 9]]}, "issue": "3-4"}, "alternative-id": ["BF01246955"], "URL": "http://dx.doi.org/10.1007/bf01246955", "relation": {"cites": []}, "ISSN": ["0300-9564", "1435-1463"], "issn-type": [{"value": "0300-9564", "type": "print"}, {"value": "1435-1463", "type": "electronic"}], "subject": ["Biological Psychiatry", "Neurology", "Psychiatry and Mental health", "Clinical Neurology"]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T06:38:49Z", "timestamp": 1574145529906}, "reference-count": 44, "publisher": "Elsevier BV", "issue": "13", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1978, 1, 1]], "date-time": "1978-01-01T00:00:00Z", "timestamp": 252460800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Biochemical Pharmacology"], "published-print": {"date-parts": [[1978]]}, "DOI": "10.1016/0006-2952(78)90550-6", "type": "journal-article", "created": {"date-parts": [[2002, 12, 14]], "date-time": "2002-12-14T00:29:45Z", "timestamp": 1039825785000}, "page": "1739-1747", "source": "Crossref", "is-referenced-by-count": 90, "title": ["Novel (\u2212)deprenyl-derived selective inhibitors of B-type monoamine oxidase. The relation of structure to their action"], "prefix": "10.1016", "volume": "27", "author": [{"given": "Joseph", "family": "Knoll", "sequence": "first", "affiliation": []}, {"given": "Zolt\u00e1n", "family": "Ecsery", "sequence": "additional", "affiliation": []}, {"given": "K\u00e1lm\u00e1n", "family": "Magyar", "sequence": "additional", "affiliation": []}, {"given": "\u00c9va", "family": "S\u00e1tory", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Biochemical Pharmacology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:0006295278905506?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:0006295278905506?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 1]], "date-time": "2019-04-01T23:29:40Z", "timestamp": 1554161380000}, "score": 28.57781, "issued": {"date-parts": [[1978]]}, "references-count": 44, "journal-issue": {"published-print": {"date-parts": [[1978]]}, "issue": "13"}, "alternative-id": ["0006295278905506"], "URL": "http://dx.doi.org/10.1016/0006-2952(78)90550-6", "ISSN": ["0006-2952"], "issn-type": [{"value": "0006-2952", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T08:39:58Z", "timestamp": 1574152798217}, "reference-count": 40, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1985, 5, 1]], "date-time": "1985-05-01T00:00:00Z", "timestamp": 483753600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Mechanisms of Ageing and Development"], "published-print": {"date-parts": [[1985, 5]]}, "DOI": "10.1016/0047-6374(85)90001-6", "type": "journal-article", "created": {"date-parts": [[2003, 2, 12]], "date-time": "2003-02-12T08:46:19Z", "timestamp": 1045039579000}, "page": "109-122", "source": "Crossref", "is-referenced-by-count": 31, "title": ["The facilitation of dopaminergic activity in the aged brain by (\u2212)deprenyl. A proposal for a strategy to improve the quality of life in senescence"], "prefix": "10.1016", "volume": "30", "author": [{"given": "Joseph", "family": "Knoll", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Mechanisms of Ageing and Development"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:0047637485900016?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:0047637485900016?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 3, 28]], "date-time": "2019-03-28T05:21:55Z", "timestamp": 1553750515000}, "score": 28.014486, "issued": {"date-parts": [[1985, 5]]}, "references-count": 40, "journal-issue": {"published-print": {"date-parts": [[1985, 5]]}, "issue": "2"}, "alternative-id": ["0047637485900016"], "URL": "http://dx.doi.org/10.1016/0047-6374(85)90001-6", "ISSN": ["0047-6374"], "issn-type": [{"value": "0047-6374", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T16:44:18Z", "timestamp": 1574095458825}, "reference-count": 17, "publisher": "Elsevier BV", "issue": "11", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1996, 2, 1]], "date-time": "1996-02-01T00:00:00Z", "timestamp": 823132800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Life Sciences"], "published-print": {"date-parts": [[1996, 2]]}, "DOI": "10.1016/0024-3205(96)00037-9", "type": "journal-article", "created": {"date-parts": [[2002, 7, 25]], "date-time": "2002-07-25T12:51:33Z", "timestamp": 1027601493000}, "page": "945-952", "source": "Crossref", "is-referenced-by-count": 12, "title": ["High performing rats are more sensitive toward catecholaminergic activity enhancer (CAE) compounds than their low performing peers"], "prefix": "10.1016", "volume": "58", "author": [{"given": "Joseph", "family": "Knoll", "sequence": "first", "affiliation": []}, {"given": "Berta", "family": "Knoll", "sequence": "additional", "affiliation": []}, {"given": "Ildik\u00f3", "family": "Miklya", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Life Sciences"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:0024320596000379?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:0024320596000379?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 30]], "date-time": "2019-04-30T04:59:01Z", "timestamp": 1556600341000}, "score": 27.97873, "issued": {"date-parts": [[1996, 2]]}, "references-count": 17, "journal-issue": {"published-print": {"date-parts": [[1996, 2]]}, "issue": "11"}, "alternative-id": ["0024320596000379"], "URL": "http://dx.doi.org/10.1016/0024-3205(96)00037-9", "ISSN": ["0024-3205"], "issn-type": [{"value": "0024-3205", "type": "print"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}